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Abstract 
The chronic nature of substance use disorder requires continuity of care after residential 
treatment. Only a small proportion of patients, however, adhere to aftercare follow-up plans and 
the relapse rates remain between 40- 80% within a year post-discharge. Synthesis of evidence 
showed that facilitated referral (FR) significantly increased follow- up adherence and resulted to 
positive outcomes. The study aimed to examine the effectiveness of FR in improving access, 
follow-up adherence and engagement to aftercare services, and relapse rate after a month post- 
discharge. After the Institutional Review Board approval, 30 participants were recruited in two 
residential treatment facilities. Questionnaires, the Assessment of Warning Signs of Relapse and 
Health leads surveys were utilized to collect data. Data were analyzed using descriptive statistics, 
McNemar, and Wilcoxon signed rank tests. Results showed that FR significantly increased 
access to many community aftercare services (p<.05). A significant reduction in relapse risk 
post-intervention was also noted (Z= -3.180, p= .001). Additionally, most participants 
discharged with scheduled appointments followed-up and had continued engagement with 
aftercare services. Eight participants maintained sobriety and 18 were lost to follow-up a month 
post-discharge, while four relapsed in the facility. Overall, FR increased access to needed 
aftercare services and significantly decreased the relapse percentage risk post-discharge. FR is a 
promising intervention that can be implemented for practice. Future research is recommended to 
further examine the correlation with follow-up adherence and continuous engagement to 
aftercare services, and relapse rate at 30 days after discharge. 
Keywords:  substance use, residential substance use treatment facility, facilitated referral, 
care transition, aftercare, healthcare accessibility, follow-up adherence, primary care, mental 
health services 
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Improving the Care Transition to Outpatient Aftercare Services Following Addiction Treatment 
Substance use disorder (SUD) had been a global concern causing a wide range of direct 
and indirect medical and social problems (U.S. Department of Health and Human Services, 
2016). Apart from causing adverse effects on mental health and doubling the risk of developing 
chronic illnesses, it can result to fatal health problems that may lead to unexpected deaths (HHS, 
2016). Unfortunately, only half of the patients discharged from substance use treatment facilities 
made initial contact with primary care and outpatient aftercare services despite the chronic 
relapsing nature of SUDs, and numerous health and social consequences associated with it 
(Arbour, Hambley, & Ho, 2011; Cucciare, Coleman, Saitz, & Timko, 2014; HHS, 2016; Manuel 
et al., 2017). Ensuring continuity of care and linkage to aftercare services after completion of 
treatment could improve the physical health, mental health, and SUD outcomes of this 
population (Arbour et al., 2011; Chi, Parthasarathy, Mertens, & Weisner, 2011; Cucciare et al., 
2014; Lash et al., 2012; Vederhus, Timko, Kristensen, Hjemdahl, & Clausen, 2014). This paper 
will explore the impact of facilitated referral to the accessibility and follow- up adherence to 
outpatient aftercare services, and to the relapse rate after discharge from a residential substance 
use treatment facility. 
Problem Statement 
Substance misuse continues to be a public health concern affecting millions of people 
worldwide. In 2012, approximately 3.5% to 7% (162 million to 324 million) of the global 
population aged 15- 64 used illicit drugs and around 5.9% (3.3 million) of global deaths were 
associated with alcohol consumption (United Nations Office on Drugs and Crime, 2014; World 
Health Organization, 2014). Nationally, about 9% (21.5 million) of the U.S. population was 
diagnosed with SUD costing taxpayers more than $600 billion annually including expenses 
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associated with crime, health, and lost productivity (HHS, 2016; Substance Abuse and Mental 
Health Services Administration, 2015b). Statistics further showed that 47,055 Americans died 
due to drug overdose and 88,000 more deaths resulted from alcohol misuse in 2014 (Rudd, 
Aleshire, Zibbell, & Gladden, 2016; Stahre, Roeber, Kanny, Brewer, & Zhang, 2014). In 
Arizona, 3.4% (177,000) of the population aged 12 or older and 6.4% (295,000) aged 21 or older 
reported illicit drug use and heavy alcohol consumption, respectively (SAMHSA, 2015a).  
The associated physical, mental, and social adverse health effects further aggravate this 
problem. About 7.9 million adults had co-existence of both mental illness and SUD with the 
highest rates among those aged 26 to 49 (42.7%) (SAMHSA, 2015b). It is also associated with 
negative social outcomes such as increased risk for driving under influence (DUI), property 
crimes, deteriorating relationships, poor school and work performance, and loss of employment 
(HHS, 2016; Thornberry & Krohn, 2006). Several studies also linked SUD with various medical 
illnesses such as hypertension, cardiopulmonary diseases, stroke, cancer, liver and pancreatic 
problems, arthritis, chronic pain, diabetes, reproductive system disorders, communicable diseases 
such as Hepatitis B, Hepatitis C and HIV/AIDS, trauma, sexual assault and rape, and other 
transportation- related injuries (Cantor et al., 2015; Center for Health Information and Analysis, 
2015; HHS, 2016; Jewett, Shults, Banerjee, & Bergen, 2015; Scott et al., 2016).  
Despite its negative health and economic impact, only 1% (2.6 million) of individuals 
diagnosed with SUD underwent treatment at specialized facilities in 2014 (Han, Hedden, Lipari, 
Copello, & Kroutil, 2015). Of those who completed the treatment, the relapse rate was estimated 
to be between 40% and 60% (National Institute on Drug Abuse, 2014). Other studies even 
reported return to maladaptive behaviors within three to four months in 60% to 80% of the 
discharged population (Arbour et al., 2011; Brown, Vik, & Creamer, 1989; Sannibale et al., 
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2003). Interestingly, only half of the patients discharged from the substance use treatment 
facilities followed- up with the outpatient aftercare services, and about 78% of individuals with 
SUD was found to have unmet mental health care needs (Arbour et al., 2011; Manuel et al., 
2017; Ross et al., 2015). Similarly, only about 40% of the patients attended 12- step meetings 
following discharge from a 28-day inpatient cocaine treatment (Rawson, Obert, McCann, Castro, 
& Ling, 1991). Another study showed that 41% of the patients entering the treatment facility had 
no primary care provider (PCP) and only a small proportion obtained primary care after 
discharge (Saitz, Mulvey, & Samet, 1997). 
The epidemiological findings of SUD and its associated health and economic 
consequences attest to the inadequacy of the traditional acute care approach in managing this 
condition. According to Dennis and Scott (2007), addressing SUDs within an acute care 
framework reduces the effectiveness of treating addicted persons towards sustainable recovery 
and abstinence. The chronic and relapsing nature of the disease spanning over the course of 
several years necessitates continuity of care and other services following addiction treatments to 
achieve full remission and recovery (Dennis & Scott, 2017; HHS, 2016). This is especially true 
during the vulnerable transitory period from the first few months to a year post- discharge when 
the risk of returning to problematic pattern of substance use and relapse are high (Arbour et al., 
2011; Carter et al., 2008). Ensuring long- term aftercare through increased access and follow- up 
adherence to outpatient aftercare services promotes management of health and ongoing 
monitoring that fosters prevention, maintenance of recovery and abstinence goals, early 
intervention, and recovery support in this population (Arbour et al., 2011; Cucciare et al., 2014; 
HHS, 2016; McKay, McLellan, Alterman, Rutherford, & O’Brien, 1998).  
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Background and Significance 
Substance use treatment facilities offer great opportunities for patient linkage and 
engagement to available aftercare services (Cucciare et al., 2014; Manuel et al., 2017). Actively 
facilitating access and follow-up adherence with aftercare plans is critical to improve health and 
substance use outcomes (Cucciare et al., 2014; Manuel et al., 2017). The study conducted by 
Manuel et al. (2017) found that the primary facilitators for effective care transition as perceived 
by the post- addiction treatment clients were patient- centered discharge planning, recovery 
check- up calls or visits, and linkage to support groups and aftercare substance use services. 
Findings indicate that early discharge preparation through individualized needs assessment (e.g. 
stable housing and employment), determination of patient goals and priorities, identification of 
community resources to address goals, and education regarding the chronic nature of SUD 
supports recovery and increases engagement with services (Manuel et al., 2017). Assisting 
clients to reconnect with supportive family and friends, and community-based recovery services 
also ensures continued progress towards addiction recovery (Manuel et al., 2017). One study 
supported this showing high- level recovery (either abstinence or at least 95% reduction in 
substance use) in 83% of participants who attended two or more aftercare substance use support 
services as compared to 71% who attended only one aftercare support service and 60% who did 
not attend any services at six- month follow- up (Arbour et al., 2011). Moreover, the result from 
a nine- year longitudinal study involving 991 participants who are post- substance use treatment 
showed that achievement of remission during follow- ups were more than twice as likely for 
those who had continuing care with at least one annual primary care visit and as needed specialty 
care visits including psychiatric and substance use treatment services (Chi et al., 2011).  
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On the other hand, a qualitative study conducted by Ross et al. (2015) identified 
collaborative, interdisciplinary care and support workers as facilitators for optimal care transition 
for clients with co-occurring disorders. The Substance Abuse and Mental Health Services 
Administration- Health Resources and Services Administration (n. d.) defined co-location as 
services located in the same building, while integration was defined as sharing the same sites, 
vision, and systems in a seamless web of biopsychosocial services. Although different, both not 
only enhance communication among providers but also increase the feasibility of access to 
quality and comprehensive care in this population (Ross et al., 2015). Evidence from research 
studies suggest that integration and co-location significantly increase primary care usage among 
persons with serious mental illnesses resulting to positive effects on health outcomes (Bradford 
et al., 2013; Druss, Rohrbaugh, Levinson, & Rosenheck, 2001; Pirraglia et al., 2012). Another 
study found that participants who received integrated medical and substance use treatment care 
showed higher abstinence rates than those assigned in the independent care group (Weisner, 
Mertens, Parthasarathy, Moore, & Lu, 2001). Similarly, significant favorable effects were noted 
on Addiction Severity Index (ASI) alcohol composite scores and abstinence rates at six months 
among patients with alcohol abuse and Hepatitis C who received integrated care (Proeschold-
Bell et al., 2012). However, despite its numerous positive effects, several barriers including 
limited financial resources and available space make this task more challenging to implement 
(Cucciare et al., 2014; Padwa et al., 2012). In this case, another option is to utilize an on-site staff 
member who will screen for discharge needs and link patients to appropriate medical and 
community support services with offsite providers through facilitated referrals (Manuel et al., 
2017; Padwa et al., 2012).  
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Facilitated referral involves conducting a health examination and psychosocial 
assessment, giving individualized education about the significance and potential benefits of 
receiving outpatient aftercare services, helping gain access to appropriate aftercare services, 
managing appointments, contacting clients after discharge to give reminders for the upcoming 
appointments, and rescheduling missed appointments if necessary (Cucciare et al., 2014; Manuel 
et al., 2017; Samet et al., 2003; Vederhus et al., 2014). This intervention facilitates linkage to 
outpatient aftercare services and promotes follow- up adherence after discharge (Cucciare et al., 
2014; Manuel et al., 2017; Padwa et al., 2012). The study conducted by Stergiopoulos et al. 
(2015) compared the effectiveness of an Integrated Multidisciplinary Care (IMCC) model to 
Shifted Outpatient Collaborative Care (SOCC) model among homeless individuals with mental 
illness and some with substance use disorder. The IMCC model involves an on-site psychiatrist 
while the SOCC model requires referral to an outpatient psychiatric consultant (Stergiopoulos et 
al., 2015). At the end of the study, evidence suggests that both care models improved measures of 
community functioning, hospitalizations, emergency department visits, and primary care visits 
without significant differences between groups over time (Stergiopoulos et al., 2015). This 
underlines the validity of facilitated referral as another option when integration or co-location is 
not feasible. The study of Samet et al. (2003) further supported this finding showing that 
facilitated referral increased primary care usage and reduced substance use among participants 
compared to those who received standard care in an addiction treatment facility. The use of 
support workers to help link patients to services and manage appointments was also perceived to 
be beneficial by both the service providers and clients with co-occurring disorders (Ross et al., 
2015).  
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Overall, current evidence suggests recognizing facilitators for care transition and utilizing 
integrated, co-located models of care or facilitated referral to help improve access and follow- up 
adherence among post- discharged SUD patients. This inquiry had led to the clinically relevant 
PICOT question: “In a residential substance use treatment facility, how does facilitated referral 
compared to usual care affect access and follow- up adherence to outpatient aftercare services, 
and relapse rate?” 
Search Sources and Process 
An exhaustive review of the literature was performed involving four electronic 
databases— The Cochrane Library (Appendix A), PubMed (Appendix B), Cumulative Index of 
Nursing and Allied Health Literature (CINAHL) (Appendix C), and PsycINFO (Appendix D). 
The search utilized keywords and relevant MeSH terms with Boolean connectors. Search terms 
that were used included: Group A (primary health care OR mental health services), Group B 
(substance abuse OR substance abuse treatment centers OR addiction treatment OR vulnerable 
populations), Group C (referral and consultation OR access to healthcare OR aftercare OR 
appointment and schedules OR follow-up studies), and Group D (continuity of health care OR 
care transition). All grouped search terms were utilized then searched in various combinations 
by using “AND” to obtain maximum yield. Limitations were applied to searches resulting to 
greater than 150 references for a more manageable initial result. The search was restricted to 
peer- reviewed journals published from 2012 to 2017, English language, humans, and age 19 and 
older. Initial yields were examined to determine relevance to the PICOT. Identified significant 
articles were then subjected to hand ancestry search for a more exhaustive exploration of the 
literature.  
CARE TRANSITION POST- RESIDENTIAL TREATMENT 11 
  
The following are specific discussions about the various search strategy combinations 
utilized in all four databases. First, the grouped search terms utilized in The Cochrane Library 
were the following: Groups A, B, C, and D yielding 0 article, Groups A, B, and C yielding 63 
articles, Groups B, C, and D yielding 2 articles, and Groups B and C yielding 574 articles. The 
search strategy resulted to a total of 639 studies that were reduced to 182 references after 
limitations were applied. Second, the grouped search strategy used in Pubmed included: Groups 
A, B, C, and D yielding 15 articles, Groups A, B, and C yielding 347 articles, Groups B, C, and 
D yielding 71 articles, and Groups B and C yielding 19 articles. This resulted to a total of 452 
studies that were reduced to 164 references after limitations were applied. Third, the grouped 
search terms used in CINAHL included: Groups A, B, C, and D yielding 1 article, Groups A, B, 
and C yielding 156 articles, Groups B, C, and D yielding 1 article, and Groups B and C yielding 
300 articles. The search strategy resulted to a total of 457 studies that were reduced to 150 
references after limitations were applied. Lastly, the grouped search strategy used in PsycINFO 
included: Groups A, B, C, and D yielding 0 article, and Groups A, B, and C yielding 636 articles. 
This resulted to a total of 636 studies that were reduced to 109 references after limitations were 
applied. 
The yields from all four databases resulted to 605 articles that were subjected to further 
evaluation.  After the initial appraisal of the studies’ abstracts and after accounting for 
redundancies a total of 49 articles were extracted. Completion of hand ancestry led to the 
identification of ten more studies. The 59 articles were then further examined producing a final 
yield of 34 studies that were subjected to critical appraisal. Consequently, 11 studies were chosen 
for literature review: one meta- analysis, two systematic reviews, six randomized control trials 
(RCT), and two quasi-experimental studies. 
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Critical Appraisal and Synthesis 
Eleven studies included in this literature review were subjected to rapid critical appraisal 
and were presented in the evaluation table (Appendix E). Melnyk and Fineout- Overholt’s (2011) 
hierarchy of evidence were utilized. Overall, the strength of the studies exhibited high level of 
evidence with one meta-analysis and two systematic reviews for level one evidence, six 
randomized controlled trials for level two evidence, and two quasi- experimental studies for level 
three evidence (Melnyk and Fineout- Overholt, 2011). The selected studies were conducted in 
various countries but more than half were in United States (Appendix F). All studies but one 
were published within the last five years with each study clearly defining the sample populations, 
and the independent and dependent variables under study. Most of the articles did not discuss the 
theoretical framework or conceptual model used however, many were found in the reference 
sections revealing a high degree of heterogeneity in the models utilized. Majority of the studies 
used randomization with clearly described measures and adequate sample sizes. Minimal 
possible biases were reported across the studies but many utilized analytic measures to minimize 
biased estimates.  
Additionally, the demographic information in the studies exhibits a moderate degree of 
homogeneity. Except for two articles, each study showed the sample’s mean age within the 
middle- aged adult population, which is between 36 to 55 years. All research articles had greater 
number of male participants than female participants reflecting the current statistics released by 
SAMHSA (2015b) that reports greater substance misuse rates among men than women. 
Moreover, majority of the retained studies were conducted in substance use treatment facilities 
with samples divided between alcohol and drugs as primary substances used. Most studies also 
had attrition rates of less than 20% with clear explanation. 
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Heterogeneity in the interventions utilized was observed. However, further evaluation 
revealed moderate homogeneity in the included components of facilitated referral having health 
assessment, individualized education utilizing motivational interviewing approach, support 
services and appointment management as the main components included in most of the 
implementation plans. Synthesis showed that most of the studies conducted interventions for 15 
to 30 minutes but a wide range of variability was observed in the frequency and duration of 
intervention sessions. The time frames for post- intervention follow- up were also varied but six 
studies had similar follow-up conducted at six months after intervention completion.  
Primary outcomes of interest mainly focused on access and follow-up adherence, and 
continued care engagement to outpatient aftercare services. Several studies also measured 
substance use severity and relapse as secondary outcomes. Measurement instruments utilized to 
measure these outcomes were moderately heterogenous but clinic records, client self-report, 
EHR, and ASI composite scores were mostly utilized. The ASI composite score is a widely used 
standardized tool that evaluates problems related to substance use (Marcus & Zgierska, 2012). It 
has been utilized across various populations including homeless substance users and individuals 
with co-occurring disorders (Marcus & Zgierska, 2012). It also demonstrated high interrater 
reliability with Chronbach’s alpha at 0.78 for alcohol and 0.68 for drug addiction severity 
(Marcus & Zgierska, 2012).   
Overall, synthesis of evidence showed moderate homogeneity exhibiting significant 
increase in access and follow- up adherence to healthcare and community- based abstinence 
support services after discharge. Continued aftercare engagement was also observed in most of 
the studies but only four of eleven studies have significant results. Moreover, facilitated referral 
also revealed significant positive impact to substance use outcomes in minority of the studies 
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evaluated. Weaknesses identified include possibility for confounding bias and small sample sizes 
in some of the variables analyzed in the studies.  
Synthesis Conclusion 
Current evidence suggests that facilitated referral is an effective intervention to increase 
follow- up adherence with outpatient aftercare services following discharge from addiction 
treatment facilities among individuals with substance use disorders. Although only few studies 
demonstrated significant positive effects on continued patient engagement and substance use 
outcomes, small improvements could still be significant considering the devastating 
consequences of this disorder to health and well-being. Adapting facilitated referral through the 
implementation of a program with strong focus on individualized health assessments, education 
utilizing motivational interviewing, support services, and appointment management could 
improve the healthcare outcomes and reduce the relapse rate of this population.  
Purpose and Rationale 
Barriers to effective transition and follow- up adherence after completion of addiction 
treatment include homelessness and presence of co-occurring disorders (Manuel et al., 2017; 
Ross et al., 2015). Internal evidence gathered in two residential substance use treatment facilities 
in Arizona on July 2016 showed that 62% of the population had dual diagnosis and 67% were 
homeless. Despite the above, there were no clear interventions to enhance follow-up adherence 
and engagement to aftercare services after discharge and there was no extension of services 
beyond the residential treatment to provide the full continuum of care once discharge from the 
facility. Improving this problem could enhance the health and prevent relapse among this 
population. For this reason, this study aimed to examine the effectiveness of facilitated referral in 
improving access, follow-up adherence and engagement to aftercare services, and relapse rate 
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after a month post- discharge. Through the implementation of facilitated referral, participants 
who completed residential substance use treatment may have increased access and engagement 
to community aftercare services, improved health through increased follow-up and engagement 
with medical provider, and decrease risk of relapse and maintenance of abstinence a month 
following discharge. 
Theoretical Model and Evidence- Based Practice (EBP) Model 
Glasser’s Choice Theory was selected to guide the proposed care transition practice 
change. This theory emphasizes that all behavior is chosen and humans can exercise control in 
their lives (Glasser, 1998). The intrinsic motivation to satisfy the basic needs influences the 
chosen behavior and building positive relationships without coercion creates a shared vision to 
pursue common goals (Glasser, 1998). The theory emphasizes four interrelated variables namely 
reality and perception, quality world, comparing place, and total behavior. According to Glasser 
(1998), there are perceived world and quality world. The perceived reality is constructed based 
from the senses, knowledge, and values while the quality world represents the created perfect 
world that is significant and the source of all motivation (Glasser, 1998). Humans compare and 
contrast between these worlds at the comparing place influencing behaviors to create a match 
between the two (Glasser, 1998). Further, Glasser (1998) posits that humans choose all behaviors 
(acting, thinking, feeling, and physiology). The first two are present in the conscious mind so 
humans have greater control with it unlike the latter two that are more present in the 
subconscious or unconscious (Glasser, 1998). However, since these components are interrelated, 
changing one can make changes to other components as well. Considering the above, facilitated 
referral can promote linkage to necessary outpatient aftercare services that may help satisfy basic 
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needs and support choice of responsible actions and thoughts that can positively change the 
emotions and physiology of addicted individuals towards better outcomes. 
Two evidence-based models were chosen to facilitate this project: a) The Model of Care 
Transitions from Addiction Treatment to Primary Care and b) The Model for Evidence- based 
Practice Change. The Model of Care Transitions from Addiction Treatment to Primary Care was 
chosen to guide the proposed care transition practice change (Appendix H). This evidence-based 
conceptual model explains and focuses on interrelated concepts and propositions namely barriers 
and facilitators, transition practices, process outcomes, and health outcomes that guide successful 
facilitation of care transitions among individuals diagnosed with SUD after discharge from 
treatment facilities (Cucciare et al., 2014). It fits the design of the proposed project that will 
follow the continuum as illustrated by the model. The project will include assessment of patient, 
provider, and system barriers and facilitators, implementation of facilitated referral, evaluation of 
healthcare access and engagement outcomes, and examination of substance use outcomes. 
On the other hand, The Model for Evidence- Based Practice Change by Rosswurm and 
Larabee (1999) facilitated this project (Appendix I). The six-step model was designed to guide 
systematic evidence- based practice change emphasizing the significance of utilizing change 
theory, research principles, and standardized nomenclature (Pipe, Wellik, Buchda, Handen, & 
Martyn, 2005). It provides solid grounds for change in practice tested in acute care settings but 
adaptable to primary care settings as well (White, Dudley-Brown, & Terhaar, 2016). This EBP 
model was chosen because the steps provide a framework for designing and implementing a care 
transition practice change to increase follow-up adherence with healthcare services and reduce 
relapse rate among persons with SUD after discharge. The six steps include: a) assessment of 
need for practice change, b) linkage of problem interventions and outcomes, c) synthesis of best 
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evidence, d) designing a practice change, e) implementation and evaluation of change in practice, 
and f) integration and maintenance of practice change (Rosswurm & Larabee, 1999). For this 
project, internal and external data were collected and compared to identify the problem regarding 
access and follow-up adherence to healthcare services after discharge from a residential 
substance use facility. These data were assessed to identify the need for practice change. 
Facilitated referral was then linked to follow-up adherence and relapse rate. Next, the best 
research evidence found through exhaustive literature search was then synthesized to determine 
whether the strength of evidence supports change in practice. After synthesis, an implementation 
plan with detailed descriptions of the process and outcome variables will be designed 
considering the feedback from stakeholders. A pilot study will then be implemented and 
continuous assessment of processes and outcomes will be performed modifying the plan based 
from these evaluations. Finally, education of stakeholders about the results and the recommended 
change will be performed if the pilot study results support integration of new practice into 
standards of care.  
Methodology 
The interorganizational collaboration involving the facility, Student Health Outreach for 
Wellness (SHOW) and iTether supported the development and implementation of the project. 
SHOW is a tri-university, interprofessional, student-led organization that offers free healthcare 
and education in the facility while, iTether develops mobile applications that serves as a platform 
to transform delivery of healthcare and integration of services. The project gained approval from 
the Arizona State University- Institutional Review Board (ASU-IRB) on September 11, 2017 
with two minor modifications during the implementation phase (Appendix J). After approval, a 
comparative study with descriptive statistics on selected variables was conducted involving a 
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convenience sample of 30 participants admitted in two residential substance use treatment 
facilities located in Phoenix, Arizona. Proposed budget was completed prior to the 
implementation of intervention (Appendix K). Facilitated referral, involving health assessment, 
individualized education with motivational interviewing, resource access support services and 
appointment management, was implemented for six months with the iTether application serving 
as a platform to educate, collect data, and communicate after discharge.  
The demographic questionnaire (Appendix L) and data collection form (Appendix M) 
were created to collect demographic data, and track progress in community resource access, 
follow-up adherence after discharge and relapse rate at 30 days post-discharge. Pre- and post- 
test of health leads screening toolkit to assess changes in social needs was used (Appendix N). 
The health leads screening toolkit was a patient-centered and well-researched instrument utilized 
for 20 years and clinically validated by sector authorities such as the Institute of Medicine, 
Centers for Medicare and Medicaid Services and the Centers for Disease Control (Health Leads, 
2018). Similarly, pre- and post- test of the assessment of warning signs of relapse (AWARE) to 
assess changes in relapse percentage risk was utilized (Appendix O). Gorski and Miller (1982) 
developed the tool to measure the warning signs of relapse following addiction treatment. It was 
originally a 37- item questionnaire found to be a good predictor of the occurrence of relapse 
(r=.42, p<.001), which was then refined to the present 28-item scale (r=0.80) with subsequent 
analyses by Miller and Harris (2000). It is a self-report questionnaire having a one to seven 
rating scale with scores ranging from 28 (lowest score possible) to 196 (highest possible score). 
Participants with higher scores have relapse rates of 33 to 46 percentage points higher than those 
with lowest scores (Miller & Harris, 2000). This 28-item questionnaire demonstrates excellent 
internal consistency with Cronbach’s alpha of .92- .93 (Miller & Harris, 2000). 
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 Data analysis was performed using the IBM SPSS 23.0 Statistics Software. Descriptive 
statistics were done to describe the data collected. Further, McNemar test and Wilcoxon signed 
rank test were utilized to assess differences between paired nominal data and paired ratio data, 
respectively. A p-value of <0.05 denotes statistically significant difference. The ASU graduate 
statistics tutorial services and faculty statistics mentor verified the accuracy of the statistical 
analyses. 
Intervention Process 
Project flyers were utilized to recruit participants during the admission assessment 
process in the facility (Appendix P). Facilitated referral was implemented among participants 
who signed the informed consent (Appendix Q). The participants were asked to fill out the 
demographic questionnaire, pre-intervention AWARE tool, and the pre-intervention health leads 
survey upon recruitment. As part of the routine care, a biopsychosocial assessment by the facility 
and SHOW, and the initiation of the care pathway form were done to evaluate discharge aftercare 
needs of participants. The researcher completed the data collection form by gathering 
information from the care pathway form and iTether application throughout the implementation 
process. During the stay in the facility, participants were asked to attend at least 15-minute 
weekly individualized educational sessions with motivational interviewing for three to four 
weeks then on as needed basis until discharge. The educational meetings followed the outline of 
educational sessions (Appendix R). Support access to needed outpatient aftercare services and 
appointment management were conducted in collaboration with the facility and SHOW. Prior to 
discharge, participants were asked to fill out the post- intervention AWARE tool. Reminder 
messages were sent a week prior to the scheduled appointments after discharge. Data regarding 
follow-up adherence and engagement to aftercare services were collected the day after the 
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scheduled appointments. If appointments were missed, education was provided about the 
importance of engagement with aftercare services and appointment reschedule was offered. At 30 
days after discharge, participants were asked to fill out the post-intervention health leads survey. 
Information regarding relapse status was also gathered. If a new need was identified, education 
regarding available resources and referral to SHOW was done as needed. Education about 
hotline numbers and available resources was provided if patient relapsed after discharge. In the 
absence of iTether, participants were contacted depending on their preferred contact modality. 
Attempts to contact the two trusted individuals identified by the participants were made if 
participants were not reached through iTether or preferred contact modality.  
Project Result 
As illustrated in Table 4 (Appendix S), data showed that the sample (N=30) had 16 males 
(53.3%) and 14 females (46.7%) with a mean age of 35.37 (SD=10.47), ranging from 20 to 59 
years. Majority of them were Caucasians (n= 13, 43.3%), had high school diploma or equivalent 
(n=14, 46.7%), were single (n=15, 50%), had prior addiction treatment (n=16, 53.3%), had 
history of imprisonment (n=25, 83.3%), had history of homelessness (n=19, 63.3%), and had 
Medicaid (n=24, 80%). Additionally, more than half of the participants were admitted 
voluntarily (n=19, 63.3%) with methamphetamines (n=10, 33.3%) and alcohol (n=8, 26.7%) as 
the most frequent primary substance used. On the other hand, the most frequent secondary 
substance utilized were methamphetamines (n=8, 26.7%) and marijuana (n=7, 23.3%). 13 
participants (43.3%) reported presence of medical condition with arthritis (n=4, 13.3%) as the 
most common medical illness. Meanwhile, 11 participants (36.7%) reported presence of 
psychiatric disease with depression (n=7, 23.3%) and anxiety (n=7, 23.3%) as the most common 
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psychiatric condition. Lastly, most participants stayed for 60 days (n=90, 30%) and majority 
were discharged to home (n=8, 26.7%).  
The McNemar test evaluated the change in social needs pre- and post- intervention 
(Appendix T). Although not all values showed statistically significant difference, the result 
suggested a decrease in requests of social needs assistance in all variables except psychiatric 
provider linkage needs. Variables with statistically significant results were smart phone needs 
(p=.002), food insecurity (p=.016), housing instability (p=.001), utility needs (p=.031), financial 
resource strain (p=.016), transportation needs (p<.001), unemployment (p<.001), 
behavioral/mental needs (p=.021), primary care provider linkage needs (p=.031) and sponsor 
linkage needs (p=.002). Unfortunately, the data also showed that only one in fifteen participants 
who expressed dental care needs got linkage to services (p=1), only five out of fourteen accessed 
eye care services (p=.063), and only one out of four obtained legal services (p=1).  
Additionally, descriptive and correlation statistics were performed to compare between 
the pre- and post- intervention relapse risk percentages (Appendix U). Results showed that the 
mean pre-intervention relapse risk percentage was 65.43 (SD=23.38), ranging from 21% to 91% 
(n=30). On the other hand, the mean post-intervention relapse risk percentage was 30.93 
(SD=21.55), ranging from 11% to 82% (n=14). The Wilcoxon Signed Ranked test were also 
completed to compare data. Data analysis showed a significant difference in the results (Z= -
3.180, p= .001), indicating a reduction in relapse risk post intervention.  
Four participants relapsed while in the facility and 12 participants were lost to follow-up 
prior to discharge (Appendix V). For this reason, correlation statistics were not performed to 
avoid biased results. Instead, descriptive statistics were utilized to examine follow-up adherence, 
engagement, and relapse rate at 30 days following completion of residential treatment. As shown 
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in Table 6 (Appendix W), ten out of fourteen remaining participants had scheduled appointments 
with PCP after discharge. Nine participants attended the PCP appointments and eight scheduled 
their next follow-up visits indicating continuous engagement. Further, all 14 participants had 
scheduled a meeting with their sponsor after discharge, with 12 attending their meetings and 
scheduling their next meeting. Similarly, 13 out of 14 participants set the date for the support 
group meeting to attend once discharged, with 12 attending their meetings and setting the next 
support group meeting to attend to. An additional six participants were lost to follow-up at 30 
days post- discharge while, eight participants reported continued sobriety (Appendix X). 
Interestingly, there was a noticeable difference between male and female. More males (n=7) 
completed the study versus females (n=1). 
Discussion 
People with SUD are highly stigmatized compared to those diagnosed with other illnesses 
(Livingston, Milne, Fang, & Amari, 2012). Unfortunately, society treats this health condition as 
a moral issue rather than a disease process and was associated with other stigmatized health and 
social factors such as sexually transmitted illnesses, poverty, criminality, and low education level 
(HHS, 2013; Livingston et al. 2012). Some of these characteristics were reflected in the study 
showing that most participants did not enter college, and had history of imprisonment, 
homelessness and prior addiction treatment. Study showed that these further aggravate the 
stigma, complicating the efforts to build social acceptance (Villa, 2018). The public exclusion 
and shaming causes profound social isolation that hinders actions to seek treatment (Villa, 2018). 
This could explain the low percentage of people entering substance use treatment. For this 
reason, the decision to enter substance use treatment facilities open great opportunities for patient 
linkage and engagement (Cucciare et al., 2014; Manuel et al., 2017).  
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The multidisciplinary team should utilize this opportunity for linkage and engagement to 
community aftercare services to address the chronic nature of the disease and promote optimal 
outcomes. Further, implementation of strategies that promote stigma reduction is critical for 
prevention and initiation of early treatment among people suffering from SUD (Prevention 
Institute, 2009). 
Additionally, the study also found that among participants with a mean age of 35 
methamphetamines and alcohol were the most frequent primary substances abused while, 
methamphetamines and marijuana were the most frequent secondary illicit drugs abused. This is 
consistent with the study conducted by Merline, O’Malley, Schulenberg, Bachman, and Johnston 
(2004) that showed alcohol and marijuana as the most frequent substance abused among 
participants aged 35 years. HHS (2013) also supported this finding stating that after alcohol, 
marijuana had the highest rate of dependence among all abused substances. On the other hand, 
Cunningham (2014) reported that in Maricopa County methamphetamine was the most common 
primary substance abused involved in treatment episodes.  
Interestingly of the 30 participants only 13 reported chronic medical conditions and 11 
reported psychiatric illness. This could be affected by age-related factors considering that most 
participants were young adults (Buja et al., 2014; Piazza, Charles, & Almeida, 2007). Further, 22 
out of 30 participants reported a need to establish a relationship to a primary care provider. The 
lack of access to a primary care physician could result to undiagnosed illnesses (Delhi & Kigali, 
2017). Moreover, the study of Albanese, Clodfelter, Pardo, and Ghaemi (2006) showed that 
bipolar disorder was frequently underdiagnosed among people with SUD.  
An encouraging finding was facilitated referral effectively increased access to most 
community aftercare needs (Lindahl, Berglund, & Tonnesen, 2013; Samet et al., 2003). 
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Facilitated referral significantly addressed smart phone needs, food insecurity, housing 
instability, utility needs, financial resource strain, transportation needs, unemployment, 
behavioral/mental needs, primary care provider linkage needs and sponsor linkage needs. 
Linkage and engagement to community aftercare services following completion of residential 
substance use treatment is critical to address the chronic nature of the disease and the social 
determinants of health that could affect overall health and substance use outcomes (Cucciare et 
al., 2014; Manuel et al., 2017). The interdisciplinary, collaborative efforts to support access of 
aftercare services among individuals suffering from SUD offers linkage that is a necessary initial 
step to derive potential benefits (Samet et al., 2003). Unfortunately, several participants reported 
dental and eye care needs but more than half cannot get access to services. The limited dental 
and vision coverage by the Arizona Health Care Cost Containment System (AHCCCS) could be 
one of the factors hindering access to these services (AHCCCS, 2018). Changes in policy to 
include preventative dental and vision services among Medicaid adult beneficiaries are 
warranted to address these significant unmet needs.  
Surprisingly, none of the participants reported exposure to violence. Studies have shown 
the association between SUD and intimate partner violence (Soper, 2014). The U.S. Department 
of Justice reported that 42% of victims used alcohol or drugs with positive toxicology screen the 
day of the assault, and women who abused substances are more likely to have experienced abuse 
in relationship(s) (Steps to Recovery, 2018). According to Fulfer et al. (2007), victims may have 
reluctance to discuss the abusive relationship due to feelings of shame, concern of disclosure, or 
fear of being blamed. Using indirect questions may help circumvent these barriers (Ashur, 1993). 
For this reason, phrasing the question in a more indirect manner could have produced a more 
accurate result.  
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Facilitated referral also significantly decreased the relapse percentage risk among the 
participants. This could be associated to the increased access and linkage to community aftercare 
services. Since social determinants of health establishes living conditions and indirectly impacts 
substance use outcomes, addressing this can lead to positive outcomes including decrease in 
relapse percentage risk (Galea & Vlahov, 2002). The residential treatment, however, was an 
extraneous variable that could have affected the result.  
The researcher was only able to follow-up with 14 out of 30 participants from admission 
to discharge due to difficulty meeting with the participants once transitioned to the intensive 
outpatient program secondary to work schedule. Out of 14 remaining participants, most 
followed-up with their aftercare services appointments scheduled after discharge with continuous 
engagement. This implies the effectiveness of facilitated referral to improve follow-up adherence 
and engagement to community aftercare services. This is consistent with the synthesis of 
evidence involving 11 high level studies (See Appendix F). Furthermore, more than half of the 
14 remaining participants maintained sobrieties at 30 days following discharge. This may imply 
the positive effect of facilitated referral to relapse outcomes however, this should be interpreted 
cautiously due to the high attrition rate of the study. Nevertheless, small improvements could still 
be significant considering the devastating consequences of this disorder to overall health. For this 
reason, policy changes to incentivize programs designed to offer the full continuum of care for 
substance use treatment including residential, outpatient, continuing care, and recovery support 
are needed to integrate care for substance use disorders and positively affect substance use 
outcomes (Sugeon General, 2018). Future research is warranted to further establish correlative 
association between facilitated referral, and follow-up adherence/ engagement to services and 
relapse rate.  
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Another interesting finding was only one female compared to seven male participants 
completed the study. This is consistent with the findings that women tend to underutilize 
substance use treatment services compared to men (Hecksher & Hesse, 2009). Women also 
prefer to seek support services from general healthcare systems rather than from specialized 
substance use facilities (Mojtabai, 2005). The study of Beckman and Amaro (1986) showed that 
women are inclined to conceal their problem of addiction from professionals due to a more 
negative attitude towards professionals than males (Hecksher & Hesse, 2009). Worse, they 
develop problems with drugs and alcohol faster and more severely than men with more adverse 
medical, psychiatric, and social consequences (Back, Contini, & Brady, 2007; Hecksher & 
Hesse, 2009). These factors could have contributed to the female participant’s high attrition rate 
and highlights the vulnerability of women suffering from SUD. With this, Hecksher and Hesse 
(2009) recommends implementation of outreach services that will overcome the barriers to 
seeking treatment for women such as motivational enhancement and treatment engagement, 
treatment coordination, monitoring, and aftercare follow-up with peer support and relapse 
monitoring.  
Lastly, the project strengths include the inter-organizational collaboration among three 
organizations that offers multidisciplinary and innovative approaches to care transition, 
utilization of high level studies to support the evidence-based intervention, use of theoretical and 
EBP models to guide the project, and protection of research participant rights through IRB 
approval. On the other hand, project limitations include inability to establish correlatives for 
follow-up adherence, continued engagement, and relapse rate at 30 days due to high attrition 
rate. Ideally facilitated referral will be continued and enhanced incorporating the intervention 
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within SHOW processes by including nursing students specializing in care transition and/ or 
social workers to sustain this project. 
Conclusion 
Facilitated referral effectively increased access to needed aftercare services post-
discharge after SUD treatment and significantly decreased the risk of relapse. This is a promising 
intervention that must be considered if the chronic disease of SUD is to be adequately addressed. 
Future research is recommended to further examine and identify best practices related to follow-
up adherence and continuous engagement to aftercare services especially as it relates to women. 
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Appendix E 
Table 1 
Evaluation Table 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Acquavita et al. 
(2013). Client 
incentives 
versus 
contracting and 
staff incentives: 
How care 
continuity 
interventions in 
substance 
abuse treatment 
can improve 
residential to 
outpatient 
transition. 
 
Country: USA 
 
Funding: 
National 
Institute on 
Drug Abuse 
(NIDA) 
 
Bias: No 
identified bias 
Inferred to be 
Social Cognitive 
Theory and 
Transtheoretical 
Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Quasi-
experimental  
 
Purpose: To 
examine the effect 
of CI and CSI to 
the rates of patient 
transition from 
residential to OP tx. 
N= 260 
CG: n= 114 
IG1 (CI): n=97 
IG2 (CSI): n= 49 
 
Demographics 
(CG/IG1/IG2): 
AA: 84%; Other: 16% 
 age: 43/43/45 
CG F/M: 36%/64% 
IG1 F/M: 40%/60% 
IG2 F/M: 37%/63% 
MS (never married): 
60%/58%/61% 
 education years: 
11/12/11 
Heroin use: 
55%/43%/57% 
MH: 27%/37%/27% 
CJR: 30%/19%/35% 
Court Ordered: 
9%/7%/16% 
 
Setting: Adult 
RSATF in West 
Baltimore, MD; 28-
IV1:CI (Scheduled 
appointments; Four 
$25 gift cards given 
per visit w/in 30 days) 
IV2: CSI (15-minute 
brief in-person 
orientation utilizing 
MI approach; 
Scheduled 
appointments; 
Continuing care 
contracts; $100- 
dollar incentive per 
participant referred 
based on successful 
enrollment) 
 
DV1: Initial contact 
DV2: Tx adm 
DV3: Receipt of OP 
appointment 
DV4: Site effects 
DV5: Time to initial 
contact 
DV6: Time to OP 
appointments 
• Records from 
EHR 
• Intake records 
SPSS version 19 
 
• Chi square 
analysis: to 
examine 
differences among 
groups at the 
nominal level 
(DV1, DV2, and 
DV3) 
 
• Z-tests between 
proportions to 
examine between 
group differences 
 
• ITT analysis: To 
include all 
participants 
irrespective of 
deviation from the 
protocol. Gives 
unbiased estimate 
of tx effect. It 
preserves the 
sample size 
(CG/IG1/IG2) 
 
DV1:  
TR: 64%/74%/84% [X2 (2, 
N=260) =8.48, p=0.014] 
TR (post-hoc): CSI> CG made 
initial contact with OP program 
(p= <0.05); CI did not differ 
significantly with either CG or 
CSI 
ITT: 58%/74%/82% [X2 (2, N= 
260) =12.29, p=0.002] 
 
DV2: 58% (150/260) were 
admitted. 
TR: 49%/60%/74% [X2 (2, N= 
260) =8.60, p=0.14] 
TR (post-hoc): only CSI and CG 
differed significantly (p= <0.05) 
ITT: 41%/60%/74% (X2 =17.62, 
p=0.000) 
ITT (post- hoc): CG differed 
significantly from both CI and 
CSI (p= <0.05) 
 
LOE: III 
 
Strengths:  
• Significant results 
• Valid study with 
comprehensive lists 
of variables 
• AR=0 
• There are no 
significant 
differences in 
baseline 
characteristics of 
subjects in each 
group 
• ITT analysis was 
done to give 
unbiased estimate 
of tx effect 
considering 
protocol deviation 
 
Weaknesses: 
• Non-randomized 
study 
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Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
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or conflict of 
interest 
 
bed short-term MM-
IRP; 8 OP referral 
sites 
 
IC: >18 y/o, 
understood English, 
admitted for ≥14 days 
EC: Prior consented 
study participant, 
lives outside 
Baltimore City or 
immediate 
surrounding area at 
time of d/c, d/c to 
specific OP tx due to 
prior affiliation or 
special needs, d/c to 
RT programs in the 
surrounding area that 
offered SUT on-site 
or at an affiliated OP 
program 
 
AR: 0 
DV7: 30-day tx 
retention (number of 
attendance) 
 
preventing reduced 
statistical power 
(DV1 and DV2) 
 
• TR analysis: To 
analyze only 
according to the 
actual 
interventions 
received 
irrespective of the 
randomized 
allocations (all 
outcome variables) 
 
• Logistic 
regression: to 
examine site 
effects for primary 
outcomes 
predicting initial 
contact and tx adm. 
Analyses with 
clinic site (on-site 
versus off-site 
clinic) and study 
condition (CG, CI, 
CSI) (DV4) 
 
• One-way ANOVA 
followed by 
Tukey’s post-hoc 
tests: used to 
analyze data with 
one independent 
and one dependent 
variable. Identifies 
specific between 
DV3: 52%/83%/92% [X2 (2, 
N=260) =63.45, p=0.000] 
Post-hoc: CI and CSI> CG (p= 
<0.05). 
 
DV4 (on-site vs. off-site clinic): 
Initial contact: 76% vs. 64% 
(Wald= 4.63, p=0.031, OR= 
1.83, CI= 1.05- 3.17) 
Tx adm: 62% vs. 52% (Wald= 
2.630, p=0.105, OR= 1.52, CI= 
0.92- 2.53) 
Study condition: non- significant 
 
DV5:  time= 3.7 days 
(SD=4.8) 
CG:  time= 4.1 days (SD=4.9) 
CI:  time= 4.4 days (SD=5.9) 
CSI:  time= 1.9 days (SD=2.6) 
(F(2, 181)=4.06, p=0.019) 
ES (CSI &CG): -0.45 (small) 
Post-hoc comparison: CSI made 
their initial contact sooner than 
CI and CG. CI did not differ 
from CG.  
 
DV6 (n=184):  time= 2.9 days 
(SD=3.8) 
CG:  time= 3.9 days (SD=4.5) 
CI:  time= 3.2 days (SD=3.8) 
CSI:  time= 1 day (SD=1.5) 
(F(2, 181)=9.07, p=0.000) 
ES (CSI &CG): -0.64 
(moderate) 
Post-hoc comparison: time to the 
appointment is shorter in CSI 
than CI and CG (p=<0.05) 
 
• Protocol deviation: 
27 participants 
assigned in CSI 
were moved to CG 
due to staffing 
changes   
• Generality of study 
findings is limited 
due to 
implementation at a 
single RSATF and 
single OP tx system 
 
Feasibility: 
• Good for use in 
practice however 
challenges may 
arise identifying 
and training CSI 
counselors and 
providing financial 
incentives 
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Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
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group differences 
(DV5, DV6, and 
DV7) 
DV7 (n=138): 91% of 
participants admitted to tx  
 number of visits= 6.2 
(SD=4.7) 
CG:  number of visits= 5.0 
CI:  number of visits= 7.4 
CSI:  number of visits= 6.1  
(F(2, 133)=3.45, p=0.035) 
Post-hoc: CI attended more 
treatment visits than CG but not 
significantly more than CSI. 
 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Blodgett et al. 
(2014). How 
effective is 
continuing care 
for substance 
use disorders? 
A meta- 
analytic review. 
 
Country: USA 
 
Funding: U.S. 
National 
Institute on 
Alcohol Abuse 
and 
Alcoholism. 
U.S. 
Department of 
Veterans 
Affairs 
 
Inferred to be 
the Continuing 
Care Model of 
Substance Use 
Treatment, CBT 
model, Trans-
theoretical 
model, Social 
Cognitive 
Theory, Chronic 
Care Model 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Meta-
analysis 
 
Purpose: To 
estimate the effect 
of continuing care 
and formally test 
several proposed 
moderators of that 
effect 
 
 
 
 
 
 
 
 
 
 
N= 33 studies 
n= 19 (assessed for 
magnitude and 
significance of the 
overall effect of 
continuing care on SU 
outcomes) 
 
Demographics for n 
Total no. of 
participants: 3,542 
 % White: 55.1% 
 % Black: 50.1% 
 % Latino: 6% 
 Age: 34.7 yrs. 
(15.9-44.4) 
M/F: 71.1%/28.9% 
 
Alcohol: 47.4% 
Drugs: 10.5% 
Both: 42.1% 
 
IV1: Continuing care 
• CBT 
• CBT-like (skills 
training, problem 
solving, 
contracting, 
incentives) 
• MET/MI 
• General/unspecified 
counseling 
IV2: Duration 
IV3: Intensity 
IV4: CBT 
 
DV1: SUD outcomes 
(aftercare 
participation, relapse 
rate and SU, 
healthcare benefit 
utilization, criminal 
activity, many more) 
DV2: Continuing care 
effects 
• Coding form 
• Moderator 
measures 
(Duration, 
Intensity, Type of 
treatment, or 
method of 
treatment 
delivery) 
 
 
 
 
 
 
 
• Comprehensive 
Meta-Analysis 
version 2.2.048 
and an R routine: 
to conduct 
moderator analyses 
• Cohen’s d: to 
calculate the 
standardized mean 
difference for 
continuous 
outcomes 
• Hedge g 
correction: for 
small sample bias 
• F- test statistic: to 
transform values 
into standardized 
mean difference 
• Aggregation 
procedures in MAd 
and RcmdrPlugin. 
IV 1 on DV1: A significant but 
small effect favored continuity 
of care over control (g=0.187, 
p=<0.001, n=18); significant 
heterogeneity of ES (I2=35%, 
Q=26.1, p=0.07). 
Last follow-up point after the 
end of continuing care: 
(g=0.271, p=<0.01, n=13); 
significant heterogeneity of ES 
(I2=76%, Q=49.2, p=<0.001). 
 
IV2 on DV2: Months of planned 
continuing care was not 
significantly associated with ES 
at the end of continuing care 
(b=0.001, p=0.66, n=17) or at 
the last follow-up point after the 
continuing care (b=0.008, 
p=0.67, n=12) 
 
IV3 on DV2: Planned sessions 
per week was not significantly 
LOE: I 
 
Strengths: 
• High level of 
evidence 
• All studies utilized 
were RCTs 
• Absence of 
publication bias per 
assessment 
• Significant results 
• Valid study 
 
Weaknesses: 
• SUD outcomes not 
specified, had to 
search for 
individual studies 
• Only 19 of 33 
studies were 
analyzed 
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Bias: No 
identified bias 
or conflict of 
interest  
 
 
 
 
Setting: inpatient 
setting (42.1%), OP 
setting (36.8%), 
Mixed (21.1%) 
 
IC: Controlled trials 
of one or more 
continuing care 
interventions for 
people with SUD, 
publication since 
1988, at least 5 
participants to each 
condition, at least one 
SUD outcome. 
 
AR: N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MAd: to combine 
all effect sizes 
within each study 
• Random effects 
model: to calculate 
overall effect sizes 
• Q- statistic: a 
measure of the 
heterogeneity of 
effect sizes 
• I2 Statistic: to 
estimate the 
percentage of 
variability in ES 
across studies that 
is due to 
heterogeneity 
• Univariate mixed- 
effects tests: to 
examine the 
aggregate effect 
size for each 
subgroup of 
categorical 
moderators 
• Meta-regression in 
R’s metafor 
program: to 
examine the 
aggregate effect 
size for each 
subgroup of 
continuous 
moderators 
 
 
associated with the effect of 
continuing care compared to 
control at the end of tx (b=-
0.027, p=0.46, n=17); last 
follow- up (b=-0.062, p=0.74, 
n=12) 
IV4 on DV2: CBT compared to 
non- CBT condition (g=0.120, 
p=0.01, I2=39%, n=12), small 
but significant effect 
CBT compared to control 
condition (g=0.195, p=<0.001, 
I2=39%, n=8), significant effect 
 
 
 
 
• Possible Type II 
error due to small 
Ns of studies 
 
Feasibility: Good for 
use in practice 
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Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Graham et al. 
(2016). Pilot 
randomized 
trial of a brief 
intervention for 
comorbid 
substance 
misuse in 
psychiatric in-
patient settings. 
 
 
Country: UK 
 
Funding: 
National 
Institute for 
Health 
Research 
(NIHR), 
Birmingham & 
Solihull Mental 
Health NHS 
Foundation 
Trust, 
University of 
Birmingham 
 
Bias: No 
identified bias 
or conflict of 
interest 
 
Inpatient- based 
service model 
 
Integrated 
service delivery 
model 
 
Inferred to be 
Transtheoretical 
Model 
Design: RCT 
 
Purpose: to 
evaluate the 
effectiveness of 
BIMI in improving 
engagement to SUT 
N= 59 
TAU: n= 29 (28 
analyzed) 
IG: n= 30 
 
Demographics 
(TAU/IG): 
Caucasian: 
58.6%/36.6% 
Asian: 17.3%/16.6% 
Black: 20.7%/30% 
Mixed: 3.4%/0% 
 age= 37.69/39.5 
yrs. 
TAU F/M= 
13.8%/86.2% 
IG F/M= 
16.7%/83.3% 
Lives alone= 
55.2%/53.3% 
 
Alcohol: 37.9%/40% 
Cannabis: 
44.8%/46.7% 
Others: 17.2%/13.3% 
 
Schizophrenia: 
65%/56.7% 
Bipolar: 24.1%/33.3% 
Others: 10.3%/10%  
 
Setting: In- patient 
units, w/in a single 
UK, NHS Trust 
including 11 acute 
wards and 3 PICUs, 
IV: BIMI (3- step 
framework delivered 
over a 2-week period 
for 4-6 sessions 
lasting 15- 30 minutes 
each with a booster 
session a month after 
completion: a) 
personalized health 
feedback and tailored 
psychoeducational 
material, b) 
Strategies’ to promote 
decision-making 
skills; peer mentor 
offered, and c) 
Encourage 
contemplation of 
change and 
identification of self- 
goals) 
 
DV1: SUT 
Engagement 
DV2: Readiness to 
change the SU 
behavior 
DV3: NOD SU 
DV4:SU Severity 
DV5: Psychological 
functioning 
DV6: Style of 
recovery from MHP 
DV7: Insight in MHP 
DV8: Cost- 
effectiveness 
• SATs 
• Client Service 
Receipt Inventory 
• Client- self report 
• Records from 
EHR 
• EQ-5D 
• Qualitative semi-
structured 
interviews 
• 8-point 
hierarchical 
motivational scale 
• 19-item Stages of 
change readiness 
and Tx eagerness 
scale 
• Importance- 
confidence ruler 
• Section B of the 
Maudsley 
Addiction Profile 
• CDUS/CAUS 
• SDS 
• AUDIT 
• RSQ 
• Insight scale 
• HADS 
• SAS version 9.4 
• ITT analysis: to 
analyze on the 
basis of the group 
to which they were 
randomized 
regardless of the tx 
that they actually 
received (all 
outcome variables) 
• Proportional odds 
model: to analyze 
ordinal categorical 
data (DV1) 
• Analogous 
generalized mixed 
models: to allow 
response variables 
from different 
distributions, such 
as binary responses 
(DV2, DV3, DV4 
and DV5) 
 
Conventional two-
sided alpha of 0.05 
 
IV:  exposure in IG= 3.14 
sessions (SD=1.92, Range 1-5); 
 duration of sessions= 18.3 
mins (SD=4.9); average total  
duration of intervention= 57.5 
mins (SD=31.33); booster 
session (n=9); Peer mentor (n=2) 
 
DV1: 63% relative odds 
increase in SUT engagement as 
measured by SATs, statistically 
significant [OR=1.63 (95% CI: 
1.01-2.65; p=0.047)] 
 
DV2: No overall statistical 
analysis due to missing data. 
Motivation to change 
Baseline: IG [6.77(SD=3.23)]; 
TAU [7.19(SD=3.58)] 
ES: -0.12 (no effect) 
Across time: IG 
[7.08(SD=3.74)]; TAU 
[6.89(SD=3.3)] 
ES: 0.05 (no effect) 
Confidence to change:  
Baseline: IG [8.12(SD=2.3)]; 
TAU [7.5(SD= 2.94)] 
ES: 0.2 (small effect) 
Across time: IG 
[8.15(SD=2.19)]; TAU 
[8.02(SD=2.83)] 
ES: 0.05 (no effect) 
 
DV3: Both groups reduced 
NOD SU by more than half 
LOE: II 
 
Strengths: 
• High- level 
evidence 
• Concealed 
randomization 
• Significant results 
• Valid study with 
comprehensive lists 
of variables 
• Cost- effectiveness 
of BIMI performed 
• AR: 1.69% with 
explanation 
• ITT analysis was 
done to give 
unbiased estimate 
of tx effect 
considering lost to 
follow- up 
 
Weaknesses: 
• Weak power: 68 
participants 
(34/group) required 
to have 90% power. 
The study only have 
59 participants. 
• Only 21/30 
participants in BIMI 
received 
intervention. 9 were 
lost to follow-up.  
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
total of 202 beds over 
a 15-mo. Period. 
 
IC: ≥18 y/o with 
schizophrenia, 
schizoaffective or 
delusional DO, 
bipolar, recurrent 
depressive DO; 
service users of 
CMHS, new adm w/in 
acute phase of SMI; 
SU over the past mo. 
with >3 score on 
CDUS/CAUS in the 
past 3 mos.; Had a CC 
in a CMHT.  
 
AR: 1.69% (1)= 
withdrawn due to risk 
DV9: Qualitative 
evaluation 
 
• B 
• FU (3 months) 
Baseline: IG [21.48(SD=11)]; 
TAU [21.23(SD= 9.68)] 
ES: 0.02 (no effect) 
Follow-up: IG 
[9.25(SD=10.82)]; TAU 
[9.31(SD=11.86)] 
ES: -0.005 (no effect) 
NOD primary SU: RR 1.02 
(95% CI=0.82-1.26; p=0.85) 
Number of SU: IG reduced by 
0.34 when compared to TAU 
[OR 0.66 (95% CI=0.33-1.33; 
p=0.24)] 
 
DV4: [IG(B/FU)/TAU (B/FU)] 
CAUS (n=12/n=11) 
Baseline: IG [3.42(SD=0.67)]; 
TAU [3.27(SD= 0.65)] 
ES: 0.23 (small effect) 
Follow-up: IG [2.25(SD=1.22)]; 
TAU [2.18(SD=0.98)] 
ES: 0.07 (no effect) 
CDUS [n=18/(n=18/n=17)] 
Baseline: IG [3.33(SD=0.49)]; 
TAU [3.28(SD= 0.46)] 
ES: 0.11 (no effect) 
Follow-up: IG [1.89(SD=0.9)]; 
TAU [2.41(SD=1.06)] 
ES: -0.5 (moderate effect) 
AUDIT [(n=12/n=9)/n=11] 
Baseline: IG [22(SD=7.76)]; 
TAU [20(SD= 8.14)] 
ES: 0.2 (small effect) 
Follow-up: IG 
[15.11(SD=7.71)]; TAU 
[13.09(SD=7.92)] 
ES: 0.26 (small effect) 
SDS [(n=18/n=14)/(n=18/n=13)] 
• Undiscussed 
between group 
characteristic 
difference 
• Participants were 
not blinded 
• Potential of 
clinician unblinding 
at 3-month follow- 
up. 
 
Feasibility 
• Good for use in 
practice however 
the implementation 
of booster session 
adherence a month 
after completion of 
treatment could be 
challenging (lack of 
staff to follow-up 
and deliver 
intervention after 
discharge) 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Baseline: IG [4.56(SD=4.23)]; 
TAU [5.11(SD= 4.93)] 
ES: -0.11 (no effect) 
Follow-up: IG [4.64(SD=4.18)]; 
TAU [5.31(SD=3.68)] 
ES: -0.2 (small effect) 
 
DV5: HADS  
Anxiety (Difference in  
 -0.80 [95% CI=3.93-2.34; 
p=0.611)]: no treatment effect 
Depression (Difference in   
-1.89 [95% CI=-4.51-0.74; 
p=0.156)]: modest effect on 
outcomes TAU >IG depression 
score 
 
DV6: RSQ 
Baseline: IG ‘adopting an 
integration style’ 
[71.14(SD=13.37)] 
TAU ‘adopting a mixed picture, 
integration predominates’ 
[66.54(SD=15.28)] 
Follow-up: Both acknowledge 
and attempt to cope with MHP 
IG ‘integration style’ 
[71.15(SD=18.97)] 
TAU ‘integration style’ [70.74 
(SD=70.74)] 
 
DV7: Insight Scale 
Awareness of symptoms 
(Difference in  0.03 [95% CI= 
-0.7-0.75; p=0.944) 
Awareness of illness (Difference 
in  0.25 [95% CI=-0.42-0.93; 
p=0.459) 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Need for tx (Difference in  
0.09 [95% CI=-0.65-0.84; 
p=0.802) 
*increased in both groups 
overtime: “good insight”  
Total (Difference in  1.03 [95% 
CI=-0.49-2.54; p=0.178) 
*difference in  implied benefit 
from BIMI, but with no 
significant differences 
 
DV8: EQ5D-5L (IG vs CG) 
(similar between groups) 
 cost of BIMI: £72 (SD=£66) 
 cost of services IG: £16,825 
(SD=£12,159) 
 cost of services TAU: 
£15,698 (SD=£12,632) 
Contact w/ psychiatrist: n=19 vs 
n= 13 
Contact w/ assertive outreach 
teams: n=7 vs n=1  
 
DV9: BIMI feasible and 
acceptable per staff and 
participants; participants 
recognize SU and impact on 
MH; useful to engage patient in 
discussions 
 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Health Quality 
Ontario.(2016). 
Interventions to 
improve access 
to primary care 
Logic Model 
 
 
Design: Systematic 
Review 
 
Purpose: To 
evaluate the 
N= 5 
 
 
Demographics: 
RCT (n=1) 
IV1: Outreach 
programs: fixed or 
mobile + CO 
IV2: Housing and 
support services (CM) 
• Grading of 
Recommendations 
Assessment, 
Development, and 
Evaluation 
Data analysis not 
discussed 
IV1 on DV: Significant increase 
in access to PCP 
 
IV2 on DV: Significant increase 
in access to PCP, MH provider, 
LOE: I 
 
Strengths: 
• High level evidence 
• Significant findings 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
for people who 
are homeless. 
A systematic 
review. 
 
Country: 
Canada 
 
Funding: None 
mentioned 
 
Bias: No 
identified bias 
or conflict of 
interest 
 
effectiveness of 
interventions to 
improve access to 
PC for homeless 
individuals 
Observational study 
(n=4) 
Total number of 
participants: 1,102 
 age: 41-54 yrs 
M: 62-100% of 
participants 
 
Setting: Community 
sites, transitional 
housing facilities, 
supported housing, 
Housed by housing 
first >6 mos. 
 
IC: Full- text, English 
Studies published 
between Jan 1 1995 to 
July 2015 comparing 
interventions to 
improve access to PC, 
homeless adult or 
child, Quantitative, 
comparative studies  
 
EC: Studies 
evaluating effects of 
intervention based on 
number of PC visits, 
studies evaluating 
effects on psychiatric 
care, screening, 
prenatal/postnatal 
care, and SU tx 
without evaluating 
access to PCP  
 
AR: N/A 
 
IV3: Integration of 
services 
 
DV: Access to 
healthcare provider 
 
 
 
(GRADE) 
Working group 
criteria 
• Cochrane’s 
Effective Practice 
and Organization 
of Care (EPOC) 
• National Heart, 
Lung, and Blood 
Institute criteria 
and SUT provider. Significant 
increase in receipt of healthcare 
services 
 
IV3 on DV: Increased access to 
PCP but no significant 
difference with CG, however 
CG received CM support. 
 
 
 
  
 
• Model stated 
• Risk of bias in 
studies was 
evaluated and 
quality of evidence 
assessed 
• Detailed description 
of search strategy  
 
Weaknesses: 
• Majority of studies 
used were 
observational 
studies 
• Possible 
heterogeneity 
between IG and CG 
• Limited 
generalizability 
 
Feasibility: Good for 
use in practice. 
Detailed explanation 
of interventions was 
outlined. 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Lenaerts et al. 
(2014).  
Continuing 
care for 
patients with 
alcohol use 
disorders: A 
systematic 
review. 
 
 
Country: 
Belgium 
 
Funding: KU 
Leuven, 
Belgian Federal 
Research 
Programme on 
Drugs 
 
Bias: No 
identified bias 
or conflict of 
interest 
 
 
Inferred to be 
the Continuing 
Care Model of 
Substance Use 
Treatment, 
Chronic Care 
Model 
Design: Systematic 
Review 
 
Purpose: To 
identify effective 
continuing care 
interventions for 
patients with AUDs  
N= 6  
 
Demographics: 
Total number of 
participants: 1,479 
 Age: 40 yrs. 
Mostly M (63- 100%) 
Apart from 1 study, 
small proportion were 
single (17.5- 34%) 
 
Setting: Outpatient 
continuing care 
facility, rehabilitation 
facility 
 
IC: RCT; adults with 
AUD as primary 
problem, receiving tx 
in an OP, continuing 
care setting, 
interventions during 
initial rehabilitation 
programs with the 
aim of increasing care 
attendance, focus on 
tx of AUD, data on 
Alcohol use outcome 
or tx engagement, 
follow-up duration of 
at least 12 weeks after 
beginning the 
continuing care phase 
 
EC: <18 yrs., inmates 
or parolees, SMI o 
IV1: Telephone calls 
IV2: Various 
psychotherapy (CBT, 
relapse prevention, 
MI, behavioral 
marital therapy, 12- 
step, interactional 
couples therapy) 
 
DV1: Alcohol use 
outcomes (% days 
abstinent, % patient 
abstinence, drinking 
severity, time to first 
drinking day) 
DV2: Tx engagement  
 
• Cochrane 
Handbook for 
Systematic 
Reviews of 
Interventions 
• Preferred 
Reporting Items 
for Systematic 
Reviews and 
Meta-Analyses 
(PRISMA) 
• Cochrane 
Collaboration’s 
risk of bias 
assessment tool 
• Microsoft Excel 
(pre-designed data 
extraction forms) 
 
 
• Review Manager 
Software 5.1: to 
calculate relative 
risks for 
dichotomous 
outcomes and 
mean differences 
for continuous 
variables 
• Random effects 
model 
DV1:  
% of patients continuously 
abstinent: 17% to 38.5% at 12 
months, non- significant 
(RR:1.40, 95% CI= 0.84-2.33); 
Overall effect: Z=1.29, p=0.20 
% of days abstinent: 39% to 
99.4%, significant (RR:10.90 
[8.83-17.96]; Overall effect: 
Z=3.02, p=0.003 
Time to first drink: 1 study 81 
days in favor of IG, 1 study 221 
days in favor of CG 
Drinking severity: + results in 
favor of IG 
 
DV2: Trend towards better 
outcomes for tx attendance than 
CG 
 
 
LOE: I 
 
Strengths: 
• High level evidence 
• Significant findings 
• Risk of bias in 
studies was 
evaluated and 
quality of evidence 
assessed 
• Detailed description 
of search strategy 
and study selection 
were discussed 
 
Weaknesses: 
• Limited 
generalizability 
• Meta- analysis 
could not be 
performed because 
of heterogeneity 
 
Feasibility: Good for 
use in practice. 
Detailed explanation 
of interventions was 
outlined. 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
other co- occurring 
SUD except nicotine, 
trials focusing on 
pharmacological 
approach 
 
AR: N/A 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Lindahl et al. 
(2013). Case 
management in 
aftercare of 
involuntarily 
committed 
patients with 
substance 
abuse. A 
randomized 
trial. 
 
Country: 
Sweden 
 
Funding: 
Ministry of 
Health and 
Social Affairs 
task force, The 
National Board 
of Institutional 
Care, The 
Skane county 
administrative 
board 
 
Transitional 
Case 
Management 
Model 
Design: RCT 
 
Purpose: To 
examine the impact 
of CM on SU and 
use of service after 
d/c from court- 
ordered 
institutional care 
N= 36 
TAU: n= 23 (21 
analyzed) 
IG: n= 13 
 
Demographics 
(TAU/IG): 
 Age: 40/34 yrs. 
TAU F/M: 26%/74% 
IG F/M: 23%/77% 
MS (Single): 91%/ 
100% 
Homelessness in the 
past 30 days: 
40%/31% 
 
Alcohol: 60%/39% 
Drug: 40%/61% 
 
Setting: 3 SUT 
institutions (Hessleby, 
Lunden, and 
Karlsvik) in Skane, 
Sweden; 11 
participating 
municipalities 
IC: Citizen in a 
participating 
municipality, 
IV: CM (Initial 
meeting to agree with 
service plan; after d/c 
weekly meetings with 
CM, monthly meeting 
with Social work; 
Protocol in 
accordance with 
CCMSAT, KEY-
CREST, and training 
manual by Swedish 
National Board of 
Health and Welfare 
for personal 
assistants) 
 
DV1: SU Abstinence 
DV2: Access to Care/ 
Use of Service after 
d/c 
• ASI-X 
• AUDIT 
• AUDRUG 
• SIP 
• Time-line Follow-
back 
• DSM IV-TR 
• SCL 
• GAF 
• Questionnaire 
Readiness to 
Change 
• MADRS 
• Involuntary care 
questionnaire 
• SPSS version 17 
• Fisher’s Exact test: 
1) to examine 
presence and 
absence of SU 
during the first 6 
months in after 
care in relation to 
TAU (DV1), 2) to 
examine hospital 
use (DV2) 
• Chi- square test: 1) 
to examine 
differences among 
groups at the 
nominal level 
(DV2: type of 
care), 2) To test 
association 
between abstinence 
and access to care 
• Binary logistic 
regression: to 
analyze three 
dependent 
variables 
(institutional care, 
health/social 
(IG vs TAU) 
 
DV1: 46% vs 14%, p=<0.05, 
ES: 0.35 (moderate) 
 
DV2: 92% vs 76%, p=0.23 
Medical- assisted tx (p=0.46) 
Institutional/inpatient care 
(p=0.27) 
NOD in inpatient care (p=0.41) 
Subgroup analysis: Abstinent 
patients had fewer NOD in 
institutional and inpatient care 
(p=0.13); Continued SU had 
access to services at significant 
level 
LOE: II 
 
Strengths: 
• High level evidence 
• Randomized 
sampling 
• Significant result 
• Model stated 
• No significant 
differences in 
baseline 
characteristics 
between groups 
• Comprehensive 
assessment of 
variables 
• AR: 5.56% with 
explanation 
 
Weaknesses: 
• Limited 
Generalizability 
• Small N 
• Risk for Type- 2 
failure regarding 
access to care due 
to low number of 
participants 
CARE TRANSITION POST- RESIDENTIAL TREATMENT 53 
AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Bias:. No 
identified bias 
or conflict of 
interest 
committed to tx at one 
of the three 
participating 
institutions for court-
ordered tx 
 
AR: 5.56% (2)= 
Deceased and 
declined 
support, and 
medication- 
assisted care) 
• Mann- Whitney: 1) 
To examine the 
NOD in institution 
or hospital care, 2) 
to test NOD of 
inpatient treatment 
• Unknown blinding 
 
Feasibility: 
• Good for use in 
practice however 
length of follow-up 
at 6 months may not 
be feasible  
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
O'Toole et al. 
(2015). 
Tailoring 
outreach efforts 
to increase 
primary care 
primary care 
use among 
homeless 
veterans: 
Results of a 
randomized 
controlled trial. 
 
Country: USA 
 
Funding: US 
Department of 
Veterans 
Affairs 
(Veterans 
Health 
Administration 
Health Services 
Research & 
Behavioral 
model for 
vulnerable 
populations 
Design: RCT 
 
Purpose: To 
examine whether 
PHA/BI or CO and 
in combination 
would increase the 
health- seeking 
behavior and 
receipt of care 
among homeless 
Veterans 
N= 185 
TAU: n= 62 
IG1 (PHA/BI): n= 39 
IG2 (CO): n= 40 
IG3 (PHA/BI+ CO): 
n= 44 
 
Demographics 
Minority: 43% 
 Age: 48.6 yrs. 
M/F: 94.6%/ 5.4% 
No income/ 
<$500/month: 75% 
 
Unsheltered: 12% 
Dusk-to-dawn 
emergency shelter: 
25.5% 
Transitional housing: 
26.1% 
Unstable doubled- up 
arrangement: 27.7% 
 
Alcohol: 69.6% 
Cocaine: 12% 
Heroin: 3.3% 
IV1: PHA/BI (20-30 
mins: feedback and 
BI through MI based 
from H&P) 
IV2: CO (15-20 mins: 
transported to clinic; 
introduced to the 
clinic team; clinic 
orientation) 
IV3: PHA/BI+ CO 
 
DV1: Number of 
participants who 
accessed PC 
w/in 4 weeks of 
enrollment 
DV2: Receipt of 
healthcare services 
post- intervention 
during 6-month study 
period 
• VA EHR 
• Face-to-face 
survey interview 
• Standardized 
surveys 
measuring self-
efficacy, social 
support networks, 
readiness for 
change 
• Descriptive 
statistics: to 
describe basic 
features of data in 
the study 
• ANOVA: To 
examine 
differences among 
groups (age, care 
usage by 
intervention) 
• Chi- square test: to 
examine variables 
at nominal level 
(done by group for 
receipt of PC at set 
intervals) 
• Fisher exact test: 
used when cell 
counts were to low 
to meet Chi-
squared 
assumptions 
• Cox proportional- 
hazards regression 
survival analysis: 
(TAU/IG1/IG2/IG3) 
 
DV1: 1-month 
FU:30.6%/41%/50%/77.3%, X2  
by group (p=<0.001) 
6-month 
FU:37.1%/56.4%/80%/88.7%, 
X2  by group (p=<0.001) 
Cox- regression analysis: 
IG2: Hazard ratio 2.64; 95% CI 
1.54- 4.53 (significant) 
IG3: Hazard ratio 3.41; 95% CI 
2.02-5.76 (significant) 
 
DV2: There was no significant 
difference in the subsequent 
number of PC (p=0.52), MH 
(p=0.06), or specialty care 
(p=0.0.11) visits per person 
across all four groups 
IG1: PC (ES:0.5- moderate); 
Specialty care consult (ES: 0.5- 
moderate effect); MH (ES: 0.92- 
large) 
IG2: PC (ES:0.25- small); 
Specialty care consult (ES: -
LOE: II 
 
Strengths: 
• High level evidence 
• Randomized 
sampling 
• Significant result 
• Model stated 
• No significant 
differences in 
baseline 
characteristics 
between groups 
• AR: 0 
 
Weaknesses: 
• Limited 
Generalizability 
• Possible 
confounding 
variable in CO arm: 
Clinic w/in 2-3 
mile-radius 
• Unknown blinding 
procedure 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Development 
Grant) 
 
Bias: No 
identified bias 
or conflict of 
interest 
 
Perceived health 
status (poor or fair): 
47.3% 
CMP: 72.7% 
MH: 71.6% 
Trauma victim: 
16.9% 
 
Setting: Providence, 
Rhode Island and 
New Bedford, 
Massachusetts; 11 
community sites and 
social service 
agencies 
 
IC: Homeless 
Veterans eligible to 
receive VA services; 
cognitively intact as 
measured by the Short 
Blessed test 
 
EC: Active cognitive 
impairment or 
delusional thought 
process that would 
impede capacity for 
health system 
navigation; Veterans 
receiving 
primary/continuity 
care from a VA- 
based provider w/in 
the last 6 mos. 
 
AR: 0 
to analyze for time 
to treatment across 
all four groups 
• McNemar’s test for 
correlated 
proportions: to 
compare personal 
motivations an 
reasons for no care 
between baseline 
and 6 months. 
0.06- no effect); MH (ES: 0.04- 
no effect) 
IG3: PC (ES:0.35- small); 
Specialty care consult (ES: -
0.09- no effect); MH (ES: 0.22- 
small) 
 
 
 
Feasibility: 
• Good for use in 
practice however 
implementation of 
CO intervention 
may be challenging 
due to lack of staff, 
transportation 
issues, no 
partnership with PC 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
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SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Samet et al. 
(2003). Linking 
alcohol and 
drug dependent 
adults to 
primary 
medical care: A 
randomized 
controlled trial 
of a multi-
disciplinary 
health 
intervention in 
a detoxification 
unit. 
 
Country: USA 
 
Funding: 
National 
Institute on 
Alcohol Abuse 
and 
Alcoholism, 
USPHS Grant 
 
Bias:. No 
identified bias 
or conflict of 
interest. 
 
Primary Care 
Model with 
Integrative- 
distributive 
approach 
 
Inferred to be 
multidisciplinary 
care model and 
Transtheoretical 
model 
Design: RCT 
 
Purpose: To assess 
the effectiveness of 
a novel 
multidisciplinary 
clinic for linking 
patients in a 
residential 
detoxification 
program to PC 
N= 470 (468 
analyzed) 
CG: n= 235 
IG: n=235 (76% 
received full 
intervention, 18% 
partial intervention, 
6% left) 
 
Demographics: 
Black: 46% 
Caucasian: 37% 
Hispanic: 11% 
Other: 6% 
 Age: 35.8 yrs. (18-
60) 
M/F: 76%/24% 
Homelessness: 47% 
 
>1 DOC: 56% 
Alcohol: 63% 
Heroin: 31% 
Cocaine: 51% 
 
CMP: 47% 
 
 
Setting: Single free- 
standing residential 
detox unit in Boston, 
MA 
 
IC: Alcohol, heroin, 
or cocaine as primary 
DOC, >17 yrs., 
residence in proximity 
IV: HELP Clinic  
• Multidisciplinary 
approach (RN, MD, 
and CM/Social 
work): each 
encounter lasted 
approximately 30 
mins 
• MI 
• Facilitated referral 
 
DV1: PC linkage at 
12 months 
DV2: SU Severity 
DV3: Health- related 
Quality of Life 
DV4: Utilization of 
medical and SU 
services 
DV5: HIV risk 
behaviors 
 
 
 
• Alcohol breath 
test 
• FU interviews 
• Clinic 
records/HER 
• ASI 
• SF-36 Health 
survey (physical 
and mental 
component) 
• RAB (HIV sex 
and drug use risk 
scale scores) 
• Self-report of ED 
visits, 
hospitalization 
and detox 
episodes 
• SAS/STAT 
software 
• ITT analysis: to 
preserve the 
sample size 
preventing reduced 
statistical power 
• Two-sample t- 
tests: to examine 
differences in 
baseline 
characteristics for 
continuous 
variables 
• Chi square test; 1) 
to examine 
differences in 
baseline 
characteristics for 
categorical 
variables, 2) to 
compare whether 
the proportion of 
subjects with FU 
differed between 
groups 
• Survival analysis, 
log rank test: to 
compare 
randomization 
group differences 
in time to linkage 
• Cox proportional 
hazards: to 
IG/CG 
 
DV1 (n=317): 69%/53% 
[p=0.0003; Hazard ratio 1.8 
(95% CI=1.3-2.4)] 
 number of visits in 12-month 
FU period: 4.7/4.9 (p=0.86) 
Alcohol-user (n=199): 72%/52% 
(p=0.0006) 
Cocaine/Heroine- user (n=247): 
67%/54% (p=0.006) 
 
Over 24-month FU period 
(DV2, DV3, DV4, DV5): 
p=>0.2 (non-significant) 
LOE: II 
 
Strengths: 
• High level evidence 
• Randomized 
sampling 
• Significant result 
• Model stated 
• Large N 
• AR: 0.42% with 
explanation 
• ITT analysis was 
done to give 
unbiased estimate 
of tx effect 
considering lost to 
follow- up 
• Baseline 
characteristics did 
not differ between 
groups 
 
Weaknesses: 
• Not current 
• Limited 
Generalizability 
• Unknown blinding 
procedure 
• Utilized self- report 
(questionable 
accuracy) 
• Lost to FU presence 
of missing data, 
however small 
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Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
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Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
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control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
to the referral PC 
clinic or homelessness 
 
EC: Established PC 
relationship, mental 
deficiencies (<21 in 
MMSE score), plans 
to leave Boston area 
in the next 12 mos., 
inability to provide 3 
contacts, pregnancy, 
not fluent in English 
or Spanish. 
 
AR: 0.42% (2) = 
Deceased 
estimate the hazard 
ratio 
• Kaplan-Meier 
method: to 
calculate estimates 
of linkage 
• Longitudinal 
regression models: 
to test for 
intervention effects 
for correlated data 
controlling for 
baseline measures 
and time points  
• Generalized linear 
model for 
correlated data: for 
analysis involving 
continuous 
measures 
• Unstructured 
working 
covariance matrix: 
to account for 
correlation 
between repeated 
measures on the 
same subject 
• Wilcoxon rank 
sum test: to 
compare annual 
rates of utilization 
between group 
 
Two-tailed, alpha of 
<0.05 
 
possibility that it 
biased results 
 
Feasibility: 
• Good for use in 
practice however 
length of follow-up 
at 6,12,18, and 24 
months may not be 
feasible 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Vederhus et al. 
(2014). 
Motivation 
intervention to 
enhance post- 
detoxification 
12- Step group 
affiliation: A 
randomized 
controlled trial.  
 
Country: 
Norway 
 
Funding: None 
 
Bias: 
Possibility of 
confounding 
bias. No 
identified 
conflict of 
interest.  
Transtheoretical 
model 
Design: RCT 
 
Purpose: To 
compare MI 
focused on 
increasing 
involvement in 12- 
Step groups versus 
BA to attend TSGs 
N= 140 
IG1 (MI): n= 68 (56 
analyzed) 
IG2 (BA): n=72 (57 
analyzed) 
 
Demographics 
(BA/MI): 
Caucasian: 96% 
Other: 4% 
 Age: 41 yrs. 
M/F: 67%/33% 
Lived alone: 47% 
 yrs. of education: 
11.2 
SUD: 96% 
Alcohol: 38%/40% 
Drugs: 43%/43% 
Both: 19%/18% 
Yrs. of problematic 
use: >11 
Previous SUD tx: 
65% 
Previous TSG 
participation: 48% 
 
Setting: Detox 
department at an 
addiction unit in 
Sorlandet Hospital, 
Kristiansand, Norway 
 
IC: Not scheduled to 
receive inpatient tx or 
opioid maintenance tx 
IV1: MI (2 weekly 
educational 30- 
minute sessions; 10-
minute motivational 
DVD; encourage to 
make a call and invite 
TSG volunteers) 
IV2: BA (Brief 
advice to attend 
meeting; meeting 
lists; brochure) 
 
DV1: TSG Affiliation 
at 6 month FU 
DV2: Frequency of 
TSG attendance 
DV3: SU Severity 
• AAAS 
• Semi-structured 
EuropASI 
• Frequency scales 
• ASI 
•  MINI 
• SPSS version 16 
• Descriptive 
statistics: to 
describe basic 
features of data in 
the study 
• GEE regressions: 
to examine 
differences 
between groups 
• ES: to estimate 
marginal means 
and between group 
differences  
 
Significance level set 
at p=<0.05 
 
*To account for 
possible imbalance 
between conditions 
due to small N, 
analyses were 
adjusted for baseline 
characteristics and 
baseline outcome 
measure value  
DV1 (AAAS):  
IV1: 2.47(SE=0.3) 
IV2: 1.56 (SE=0.38) 
[0.91 adjusted point difference; 
95% CI=0.04-1.78; p=0.041], 
0.48 higher AAAS score at FU 
(beta=0.48; SE=0.09; p=<0.001) 
 
DV2: 
IV1: 16(SE=3.8) 
IV2: 8.2 (SE=2.2) 
[5.9 adjusted point difference; 
95% CI=-1.4-13.2; p=0.115] 
 
DV3: 
Alcohol-use in the last 30 days: 
IV1: 2.2(SE=0.8) 
IV2: 5.4(SE=1.3) 
[-3.5 adjusted point difference; 
95% CI=-6.5- -0.6; p=0.02] 
Alcohol use severity 
(EuropASI): 
IV1: 0.17(SE=0.03) 
IV2: 0.24 (SE=0.03) 
[-0.06 adjusted point difference; 
95% CI=-0.14-0.01; p=0.095] 
Drug-use in the last 30 days: 
IV1: 4.8(SE=1.3) 
IV2: 7.4 (SE=1.6) 
[-4.0 adjusted point difference; 
95% CI=-7.5- -0.4; p=0.028] 
Drug use severity (EuropASI): 
IV1: 0.11(SE=0.02) 
IV2: 0.1 (SE=0.01) 
[0.00 adjusted point difference; 
95% CI=-0.03-0.03; p=0.862] 
LOE: II 
 
Strengths: 
• High level of 
evidence 
• Significant results 
• AR with 
explanation 
• Comprehensive 
assessments of 
variables 
• Use of standardized 
instruments 
• FU completion by 
an interviewer 
blinded to 
assignment 
condition 
 
Weaknesses: 
• Lack of individual 
randomization 
• AR: 19.29% 
• Reliance on self-
reports 
• Use of estimated 
number of TSG 
meetings to conduct 
the sample size 
calculation 
• Possibility of 
confounding factor 
(intensity of 
intervention 1 hour 
vs few minutes) 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
after detox, remained 
in detox sufficiently 
long for assessment, 
planned d/c to home 
 
EC: SMI, cognitive 
impairment, no access 
to at least 1 TSG 
within 30 km of home 
 
AR: 19.29% (22 lost 
to follow-up, 3 
deceased, 2 refused) 
Abstinence rate: 
Participants who attended TSG 
meetings: 62% 
Non-attendees: 26% 
(X2 =14.5, p=<0.001) 
 
 
 
 
 
 
 
• Limited 
generalizability 
• No correction was 
made for inflated 
type I error 
associated with 
multiple 
comparisons of 
secondary outcomes 
 
Feasibility: Good for 
use in practice 
however length of 
follow-up at 6 months 
may not be feasible 
 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Weisner et al. 
(2016). 
Examination of 
the effects of 
an intervention 
aiming to link 
patients 
receiving 
addiction 
treatment with 
healthcare: The 
LINKAGE 
clinical trial.  
 
Country: USA 
 
Funding: 
National 
Institutes of 
Inferred to be 
Social Cognitive 
Theory and 
Health 
Promotion 
Model 
Design: NRCT 
 
Purpose: To 
examine the effects 
of an intervention 
aiming to link 
patients receiving 
addiction tx in HC 
N= 503 
CG: n= 251 
IG: n=252 (six 45-
minute group-based, 
manual-guided 
sessions: 2/week; 
practiced skills 
necessary for 
collaborative 
communication) 
 
Demographics 
(CG/IG): 
Caucasian: 
59.8%/61.9% 
Hispanic: 
20.7%/19.4% 
African American: 
8%/6.7% 
IV: LINKAGE 
intervention  
• Group-based, 
manual guided 
sessions on patient 
engagement 
• EHR use 
• Facilitated 
physician 
communication 
 
DV1: Patient 
activation 
DV2: Patient 
engagement in HC 
DV3: SU Abstinence 
DV4: Depression 
outcomes 
• Telephone 
interviews 
• HER 
• Patient Activation 
Measure 
• ASI 
• National Institute 
on Alcohol Abuse 
and Alcoholism 
evidence-based 
questionnaire 
• PHQ-9 
 
Two-tailed, alpha 
level of 0.05 
• SAS version 9.3 
• ITT analysis: to 
preserve the 
sample size 
preventing reduced 
statistical power 
• Longitudinal 
Poisson regression 
models with quasi 
likelihood 
approach: to 
analyze patient 
portal use 
• General linear 
regression: 1) to 
examine 
comparability 
between conditions 
on baseline 
IG/CG 
 
DV1:  
Full sample: [129 of 225 
(57.3%)] vs [116 of 230 
(50.4%)], p=0.14 
Subsample with MHP: [104 of 
172 (60.5%)] vs [92 of 182 
(50.6%)], p=0.06 
 
DV2: Patient portal use 
IG showed 1.53-fold increase in 
 number of log-in days (IRR: 
1.53; 95% CI=1.19-1.97; 
p=0.001) 
 number of log-in days for 
medical advice (IRR: 1.55; 95% 
CI=1.13-2.11; p=0.006) 
LOE: III 
 
Strengths: 
• Baseline 
characteristics did 
not differ between 
groups 
• Valid study 
• Significant results 
• AR=0 
• Comprehensive 
assessments of 
variables 
• Use of standardized 
instruments 
• Large N 
 
Weaknesses: 
CARE TRANSITION POST- RESIDENTIAL TREATMENT 59 
AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
Health Center 
Grant from 
NIDA 
 
Bias: No 
identified bias 
and conflict of 
interest. 
Asian: 7.2%/6.3% 
Other: 4.4%/5.6% 
 Age: 42.5 yrs. 
M/F: 69%/31% 
≤HS or GED= 
42.6%/38.1% 
 
Alcohol: 47%/42.5% 
Drugs: 26.7%/24.2% 
Both: 16.3%/25% 
MH (moderate to 
severe depression): 
13.5%/15.1% 
 
Setting: San 
Francisco OP 
addiction tx clinic of 
Kaiser Permanente 
 
IC: ≥18 yrs. deemed 
eligible by physicians 
after completing a 10-
day stabilization 
program 
 
EC: Severe cognitive 
disability, SMI 
 
AR: 0 
DV5: Effects of the 
number of linkage 
sessions  
DV6: Effects of 
facilitated physician 
communication 
 
FU:6 months 
characteristics for 
continuous 
variables, 2) to 
examine the 
intervention effect 
on nonportal 
outcomes at 6 
months for 
continuous 
measures 
• Chi- square test: 
To examine 
comparability 
between conditions 
on baseline 
characteristics for 
categorical 
variables 
• Logistic 
regression: to 
examine the 
intervention effect 
on nonportal 
outcomes at 6 
months for binary 
measures 
• Bonferroni 
correction: to 
account for 
multiple 
comparisons 
• Exploratory 
analysis: to 
examine the effect 
of the number of 
LINKAGE 
sessions attended 
and facilitated 
 number of messages sent by 
HC professional (IRR: 1.45; 
95% CI=1.08-1.94; p=0.02) 
 number of log-in days for lab 
results review (IRR: 1.92; 95% 
CI=1.43-2.56; p=<0.001) 
 number of log-in days for lab 
test information (IRR: 1.89; 95% 
CI=1.43-2.51; p=<0.001) 
Subsample with MHP: IG 
showed significantly higher use 
of each activity 
PCP communication about SUD: 
IG had twice the odds of 
communicating with PCP about 
SUD (OR 2.30; 95% CI=1.00-
2.57; p=0.05) 
 
DV3: Full sample (OR 1.17; 
95% CI=0.79-1.75; p=0.43) and 
subsample with MHP (OR 2.05; 
95% CI=0.7-6.06; p=0.19) 
*Both groups had high SU 
abstinence rates at 6 mos. w/o 
significant differences between 
conditions 
 
DV4: IG (PHQ-9 dropped from 
15.1% to 8%); CG (PHQ-9 
dropped from 13.5% to 7%) 
*No significant differences 
between conditions 
 
DV5 (IG >6 vs <6 sessions): 
Significantly higher patient 
portal use, alcohol abstinence 
rates (83.7% vs 71.7%; p=0.03), 
total abstinence rates (77.6% vs 
• Non-randomized 
trial 
• Patient activation 
may have been 
underpowered 
• Did not include 
biological 
specimens in FU 
 
Feasibility: Good for 
use in practice but 
may have challenges 
with intervention 
implementation 
(system changes, lack 
of staff, follow-up in 6 
months) 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
physician 
communication on 
each outcome 
65.4%, p=0.05), and longer tx 
retention (103 vs 60 days; 
p=<0.001) 
 
DV6: Significantly more 
communicated with PCP 
regarding SU, longer tx retention 
(92 vs 49.3 days, p=<0.001), 
better alcohol abstinence (82% 
vs 62.7%, p=<0.001), and less 
heavy drinking (8.9% vs 26.9%, 
p=<0.001) 
 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/ Application 
to practice 
Zanjani et al. 
(2015). 
Management of 
psychiatric 
appointments 
by telephone.  
 
Country: USA 
 
Funding: 
National 
Institute of 
Health 
 
Bias: No 
identified bias 
and conflict of 
interest. 
Inferred to be 
Transtheoretical 
model 
Design: RCT 
 
Purpose: To 
examine a system 
for PAM in 
community patients 
N= 39 
CG: n= 20 
IG: n=19 
 
Demographics: 
Racial minority: 14% 
 Age: 43 yrs. 
M/F: 51%/49% 
*Most were white, 
married, lives alone, 
with full-time work. 
 Income: $42,000 
Yrs. of education: 15 
yrs. 
 
Setting: University of 
Kentucky OP 
Psychiatric clinic 
 
IC: Not receiving 
psychiatric care in the 
previous yr, 2-week 
IV: TBI-BMI (PAM) 
(Brief MI for 15- 20 
mins; completed 
workbook; 
appointment 
reminder; letter to 
reinforce tx 
engagement; 
rescheduling 
appointment) 
 
DV1: Tx attendance 
DV2: Depression 
DV3: Psychiatric 
symptoms 
DV4: Psychiatric 
comorbidity 
DV5: Quality of Life/ 
Functioning 
DV6: Perceived tx 
barriers 
 
FU: 6 months 
• Clinic records 
• Brief depression 
severity measure 
• Brief symptom 
Inventory 
• MINI 
• SF-36 
• Treatment barriers 
inventory 
 
• Linear mixed 
models: for 
analysis involving 
continuous 
measures 
• Other statistics 
used not discussed 
 
 
 
 
 
 
 
IG/CG 
 
DV1: 
Attendance at initial 
appointment (90% vs 60%, 
p=0.035) 
Total number of appointments 
attended: at 6 (3 vs 2.5, p=0.63) 
and 12 months (3.7 vs 3.2, 
p=0.64) 
Attending at least 3 
appointments (58% vs 42%, 
p=0.26) 
 
DV2: p=<0.001 
DV3: p=<0.001 
DV4: p=0.004 
DV5: Physical functioning 
(p=0.56); Mental functioning 
(p=<0.001) 
DV6: p=0.3 
 
LOE: II 
 
Strengths: 
• High level of 
evidence 
• Randomized 
• Valid study with 
comprehensive 
assessments of 
variables 
• Baseline 
characteristics did 
not differ between 
groups 
• Use of standardized 
instruments 
• AR=0 
Weaknesses: 
• Unknown blinding 
procedures 
• Small N 
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AAAS- AA Affiliation Scale, Adm- admission, AR- Attrition Rate, ASI-X- Addiction Severity Index, AUD- Alcohol Use Disorder, AUDIT: Alcohol Use Disorders Identification Test, B- Baseline, 
BA- Brief Advice, BIMI- Brief Integrated Motivational Intervention, BMI- Brief Motivational Intervention, CBT- Cognitive Behavioral Therapy, CC- Care Coordinator, CCMSAT- Comprehensive 
Case Management for Substance Abuse Treatment, CCI- Continuing Care Interventions, CDUS/CAUS- Clinicians Alcohol/Drugs Use Rating Scale, CI- Client Incentive, CG- Control Group, CJR- 
Criminal Justice Referral, CM- Case Management, CMHT- Community Mental Health Team, CO- Clinic Orientation, CMP- Chronic Medical Problem, CSI- Contracting with Staff Incentives, d/c- 
discharge, DO- disorder, DOC- Drug of Choice, DV- Dependent Variable, EC- Exclusion Criteria, ED- Emergency Department, EHR- Electronic Health Record, ES- Effect size, F-female, FR- 
Follow- up Rate, FU- Follow- up, GAF- Global Assessment Functioning Scale, GEE- Generalized estimating equation, HADS- Hospital Anxiety and Depression Scale, HC- Healthcare, IC- Inclusion 
Criteria, IG- Intervention Group, IV- Independent Variable, ITT: Intention to treat, LOE: Level of evidence, M- Male, MADRS- Montgomery- Asberg Depression Rating Scale, MET: Motivational 
Enhancement Therapy, MH- Mental History, MHP- Mental health problems, MI- Motivational Interview, MINI- Mini International Neuropsychiatric Interview, MM-IRP- Medically Monitored 
Intensive Residential Program, mo/s- month/months, MMSE- Mini-Mental State Examination, MS- Marital Status, NHS- National Health Service, NOD- number of days, NRCT- Non- randomized 
control trial, OP- Outpatient, PAM- Psychiatric Appointment Management, PC- Primary Care, PCP- Primary Care Physician, PHA/BI- Personal Health Assessment/Brief Intervention,  PICU- 
Psychiatric Intensive Care Units, RAB- Risk Assessment Battery, RR- Risk Ratio, RSATF- Residential Substance Abuse Treatment Facility, RSQ- Recovery Style Questionnaire, RT- Residential 
Treatment, RCT- Randomized Control Trial, SATs- Substance abuse treatment scale, SCL- Symptom check list, SDS- Severity of Dependence Scale, SE: Standard Error, SIP- Short Index of Problems, 
SU- Substance Use, SUT- Substance Use Treatment, SMI- Severe Mental Illness, TAU- Treatment As Usual, TBI- Telephone- based Intervention, TR- Treatment received, TSG- Twelve Step Groups, 
tx- treatment, VA- Veteran’s Administration, w/in- within 
  
window between 
recruitment and first 
appointment 
 
AR: 0 
 
• Unknown cost- 
benefit ratio 
 
Feasibility: 
• Good for use in 
practice however 
length of follow-up 
at 6 months may not 
be feasible 
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Appendix F 
Table 2 
Synthesis Table 
Authors 
 
Acquavita Blodgett Graham 
Health 
Quality 
Ontario 
Lenaerts Lindahl O’Toole Samet Vederhus Weisner Zanjani 
Year 2013 2014 2016 2016 2014 2013 2015 2003 2014 2016 2015 
Country USA USA UK Canada Belgium Sweden USA USA Norway USA USA 
Study Characteristics 
Design/ LOE 
MA- SR/I  X  X X       
RCT/II   X   X X X X  X 
NRCT/III X         X  
Setting 
SATF X X   X X  X X X  
PF   X        X 
CS/SSA    X   X     
Demographics 
Sample Size 260 3542 59 1102 1479 36 185 470 140 503 39 
Mean Age and Gender 
Young adult (18-
35 years)  X      X    
Middle- aged (36-
55 years) X  X X X X X  X X X 
M>F X X X X X X X X X X X 
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Primary Substance- Used 
Alcohol  X  ND ND X X X  X ND Drugs X  X    X  
Intervention and Included Component of Facilitated Referral 
 CI CSI CC BIMI ORP+CO TBI + 
PT 
CM PHA- 
BI 
CO PHA/BI+ 
CO 
HELP 
clinic 
MI 
compared 
to BA 
LINKAGE TBI-MI 
Health 
Assessment    X X  X X X X X  X  
Individualized 
education 
utilizing PT 
 X (MI) 
X (CBT; 
CBT-like; 
MET/MI; 
Counselling) 
X 
(CBT; 
MI) 
X (MI) 
X (CBT; 
MI; MET, 
TSF, etc.) 
X X (MI) 
X 
(MI) 
X  
(MI) 
X 
(MI) X(MI) 
X (Patient 
activation) X (MI) 
• Impact to health 
and importance 
of follow-up 
adherence 
 X 
ND 
X X X  X X X X X X X 
• Barrier 
identification, 
problem- 
solving, goal 
discussion, 
communication 
skills 
  X X X X     X X X 
• OP clinic   X  X    X X    X 
Managing 
appointments  X X 
ND 
 
ND 
X     X X  X 
• Scheduling X X  X     X X  X 
• Reminder         X   X 
• Follow-up if 
missed X X          X 
Financial 
incentives X X             
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Contracting  X     X       X 
Referral letter 
with patient 
information 
          X    
Peer mentor and 
other support 
X 
(T) 
X 
(T)  X 
X (CM; 
T) X (RN) X (CM)  
X 
(T) X (T)     
Patient EHR 
Utilization             X  
Length of intervention 
15- 30 minutes X X ND X   ND X X  X X  X 31- 45 minutes        X   X  
Frequency and 
Duration of 
sessions 1 prior to d/c 
Majority: 
Duration 
were 3 
months 
4-6 in 2 
weeks 
+1 
booster 
a month 
after d/c 
Variable 
 
Majority 
were 1-
2/ week 
 
1 every 
week 1 3 2/ week 
6 in 3 
weeks 
1 (2 weeks 
prior to 
appointment)  
Follow- up 
30 days X   
Variable Variable 
 X     
3 months  X X       
6 months    X X X X X X 
>6 months    X  X   X 
Instruments 
Clinic records, 
Client self- report 
and EHR 
X  X    X X  X X 
CSRI   X         
SATs   X         
Motivational Scale   X         
Stages of Change 
Readiness and Tx 
Eagerness scale 
  X   X X     
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CDUS/CAUS   X         
SDS   X         
AUDIT   X   X      
GAF      X      
Insight scale   X         
HADS   X         
DSM IV      X      
ASI      X  X X X  
PHQ-9          X  
MADRS      X      
Self- efficacy       X     
AAAS         X   
MINI         X  X 
Patient Activation 
Measure          X  
Brief depression 
Severity measure           X 
Tx Barrier 
Inventory           X 
Findings 
 CI CSI CC BIMI ORP+CO TBI + 
PT 
CM PHA- 
BI 
CO PHA/
BI+ 
CO 
HELP 
clinic 
MI 
compared 
to BA 
LINKAGE TBI-MI 
Access and follow 
up adherence to HS ≠ *   *   ≠ * * * *  * 
Continued 
aftercare 
engagement 
* ≠ *+ Se * Se   ≠ ≠ ≠ ≠ ≠ ≠ * ≠ 
Time to initial 
contact = 
* 
Se             
Receipt of OP 
appointment * *             
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Time to OP 
appointment = 
* 
Me             
Tx Admission * *             
SU Outcomes   *+ Se +  *+ *+ Me    ≠ *+ +  
PT effect on SU 
Outcomes   *+Se            
MH Outcomes    +         + *+ 
Duration of tx   ≠            
Intensity of tx   ≠            
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Appendix G 
Model 1 
Choice Theory by Glasser 
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Appendix H 
Model 2 
Model of Transitions from Addiction Treatment to Primary Care 
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Appendix I 
Model 3 
 The Model for Evidence-Based Practice Change by Rosswurm and Larabee 
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Appendix J 
Document 1 
 Institutional Review Board Approval Letters 
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Appendix K 
Table 3 
 Proposed Budget 
Projected Costs 
 Expenses In-kind support 
Personnel   
Project Director 
$30/hour for 5 hours per 
week x 24 weeks 
 $3,600.00 
Advanced primary care 
provider (NP/PA) 
$50/hour for 5 hours per 
week x 20 weeks 
 $5,000.00 
Advanced psychiatric 
nurse practitioner 
$50/hour for 5 hours per 
week x 20 weeks 
 $5,000.00 
Social worker 
$22/hour for 5 hours per 
week x 20 weeks 
 $2,200.00 
Office Staff 
$19/hour for 6 hours per 
week x 20 weeks 
 $2,280.00 
Software Developer 
$18/hour for 6 hours x 4 
weeks 
 $432.00 
Resident’s time 
15 minutes x stay in weeks 
plus 4 weeks 
No cost because patient lives in 
residential facility and interventions will 
not interfere with patients’ schedules 
 
Equipment and supplies   
Printed forms, research 
tools, and educational 
materials 
-Computer/Laptop 
-Tablet 
-Relapse prevention card 
-Educational tool 
-Researcher phone +6 
month prepaid 
 
Cellphone 
 
 
 
 
 
$20.00 
$100.00 
            $200.00 
 
 
 
 
$250.00 
$100.00 
 
 
 
 
 
$80.00 
Total expenses $320.00 $18,942.00 
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Appendix L 
Instrument 1 
 Demographic Questionnaire 
 Please fill in the blank or check the appropriate box for each of the following questions. 
1. What is the reason for your admission?                
      Mandated to treatment/ Pre-trial            Voluntary                Other: __________________ 
2. In what program are you enrolled? 
      Right track phase I                     Right track phase II                Intensive Outpatient program 
3. Do you have prior history of addiction treatment?         No             Yes 
4. Have you ever been imprisoned or incarcerated?           No            Yes 
If yes, were you in prison just before entering the program?           No            Yes 
5. Have you ever been homeless?              No            Yes    
6. What is your primary substance of choice?    
           Alcohol                         Ecstasy                                      Methamphetamines 
           Opioids                         Cocaine                                      Bath salts 
           Benzodiazepines           Heroin                                       Marijuana 
           Others: __________________________________________________________________ 
 
7. What is your secondary substance of choice?  
           Alcohol                         Ecstasy                                      Methamphetamines 
           Opioids                         Cocaine                                      Bath salts 
           Benzodiazepines           Heroin                                       Marijuana 
           Others: __________________________________________________________________ 
 
8. Presence of medical health condition(s)?       No         Yes 
 If yes, select all that apply:  
      Hypertension               Diabetes                                     Cancer 
      Hyperlipidemia            Thyroid problems                      Hepatitis  
      Heart Failure                Chronic Back problems             Liver cirrhosis 
      Asthma                         Arthritis                                     Sexually Transmitted Illnesses 
      COPD                          Irritable bowel syndrome           Insomnia 
      Psoriasis                       Crohn’s disease                         Chronic Kidney Disease 
      Seizure Disorder          Others: ____________________________________________ 
 
9. Presence of psychiatric condition(s)?            No          Yes 
      If yes, select all that applies:  
           Depression                    ADHD/ADD                             Eating disorder 
           Anxiety disorders          PTSD                                        Bipolar disorder 
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           Others: _________________________________________________________________ 
 
10. Do you have a smart phone?            No        Yes 
 
11. Contact information:  
a. Personal contact information (This will be used if you are not responding or not eligible to 
enroll in iTether)  
 Preferred way to contact you for appointment reminders (May choose more than one):          
      Text: ______________ (cell phone number)           E-mail: ______________________    
 Preferred way to contact you for follow-ups (May choose multiple):  
      Text: ______________ (cell phone number)           E-mail: ______________________      
      Call (landline/cellular): _________________ (landline or cellphone number) 
b. Provide at least two trusted contact persons: (This will be used only if you cannot be 
reached) 
 
 First Name: _______________________________Relationship: ___________________ 
  Contact no: _____________________________________________________________ 
 
 First Name: _______________________________Relationship: ___________________ 
  Contact no: _____________________________________________________________ 
 
 First Name: _______________________________Relationship: ___________________ 
  Contact no: _____________________________________________________________ 
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Appendix M 
Instrument 2 
 DNP Data Collection Form 
 Pre- intervention data collection (Needs Assessment: Completed by the researcher) 
 
1. What is the status of primary care relationship? 
      Has established relationship with one PCP  
      Has established relationship with one PCP but last appointment was >2 years ago 
      Has established relationship with one PCP but requests a different provider 
      Has established relationship with one PCP but has issues with location 
Has no established relationship with one PCP and needs linkage 
Has multiple PCPs 
Others: ____________________________________________________________ 
 
2. What is the status of psychiatric provider relationship? (Skip if not applicable) 
      Has established relationship with one psychiatric provider  
            Has established relationship with 1 psych provider but last appointment was >2 yrs ago 
Has established relationship with one psychiatric provider but requests a different one 
Has established relationship with one Psychiatric provider but has issues with location 
Has no established relationship with one psychiatric provider and needs linkage 
Has multiple psychiatric providers  
Others: ____________________________________________________________ 
 
3. What is the sponsorship status?  
Has established relationship with a sponsor 
Has no established relationship with a sponsor 
Unable to contact sponsor 
Requests a different sponsor 
Others: ____________________________________________________________ 
 
4. Are there other social work/community aftercare needs? (Select all that apply)  
      Access to dental care 
      Access to vision care  
      Access to AA/NA meetings after discharge or other community recovery support 
groups 
       Needs sober living arrangement     
       Needs linkage with individual/family counselling services 
       Needs legal services 
       Others: ______________________________________________________________ 
 
  Intervention data collection (Completed by the researcher) 
1. Weekly educational sessions received (At least 15 minutes per session): 
       Date: ___/___/___                Date: ___/___/___                    Date: ___/___/___          
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       Date: ___/___/___                Date: ___/___/___                    Date: ___/___/___          
       Date: ___/___/___                Date: ___/___/___                    Date: ___/___/___          
       Date: ___/___/___                Date: ___/___/___                    Date: ___/___/___             
 
2. What are the support services and resource tools provided to help access and increase 
follow-up adherence to needed outpatient aftercare services? 
       Resources provided regarding: 
                         Food assistance provided in the community 
                         Housing  
                         Utility payment assistance 
                         Financial Assistance 
                         Transportation 
                         Domestic violence/Trauma assistance and resources 
                         Assistance with Childcare  
                         Health literacy/Education needs 
                         Employment resources and linkage support 
                         Mental/Behavioral health resources 
                         Community clubs/ Church 
                         Dental care resources 
                         Eye care resources 
                         Counselling resources 
                         Legal services  
       Consulted Social Work 
       Insurance application support 
       Access to directory of providers covered by insurance (Primary care and/or Psych 
services) 
       Support with appointment scheduling and management 
       List of AA/NA meetings scheduled post- discharge 
       List of sponsors 
       Discharge tools:  
                         Relapse prevention card 
                         Post-discharge appointment schedule form/ iTether calendar 
       Others: ______________________________________________________________ 
 
3. Number of PCP appointments while admitted: _____ 
4. Number of psychiatric appointments while admitted: _____  
5. Number of sponsor meetings while admitted (1 hour/week): _____  
 
  Post- intervention data collection 
1. Post-discharge: 
 
 Prior to discharge 
• Do you have an appointment scheduled with your primary care doctor after leaving the 
program?      Yes          No           N/A 
   If yes, date of appointment after discharge: _______________________________ 
   PCP: _____________________________________ City/Zip code: _________ 
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   Contact number:  _______________________________________________ 
                        
   If no, what is the reason: ______________________________________________ 
 
• Do you have an appointment scheduled with your mental health provider after leaving the 
program?       Yes        No       N/A 
              If yes, date of appointment after discharge: _______________________________ 
  PCP: _____________________________________ City/Zip code: _________ 
  Contact number:  _______________________________________________ 
                        
  If no, what is the reason: ______________________________________________ 
 
• Do you have a sponsor?        Yes          No          
 If yes, date of first meeting after discharge: _______________________________ 
 If no, what is the reason: ______________________________________________ 
 
• Do you have a scheduled AA/NA meeting to attend?         Yes          No        N/A 
 If yes, date of first AA/NA meeting after discharge: _________________________ 
 If no, what is the reason: ______________________________________________ 
 
• What other community assistance were you able to access? (Check all that apply) 
           Food Assistance           Utility payment assistance         Financial assistance 
           Insurance                      Counseling services                   Domestic violence support  
           Housing                        Employment                              Transportation 
           Legal services              Sober living arrangement           Education opportunities 
           Dental services             Vision/ Eye glasses                    Child care services 
           Social support (Community clubs/ Church)                     Others: ______________________ 
 
** If other identified needs were not successfully provided, what are the reasons?: 
______________________________________________________________________________ 
  
a. Did you decide to extend your stay at Crossroads?         Yes           No        
      What is your total length of stay in the facility? 
            30 days       60 days      90 days          Other: ________________ 
 
b. Where will you be discharged? 
                        IOP         Sober living     Home        Prison        Other: ________________ 
 
 Within 30 days of discharge 
a. Did you attend your scheduled appointments with your: 
• Primary care provider        Yes        No        N/A            
    If no, what is the reason: _____________________________________________                           
          education provided and appointment rescheduled?       Completed               
• Psychiatric provider        Yes         No        N/A    
     If no, what is the reason: _____________________________________________                           
          education provided and appointment rescheduled?       Completed 
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• Sponsor meeting        Yes          No     
     If no, what is the reason: _____________________________________________ 
          education provided and encouraged participant to call sponsor?       Completed 
  
• First AA/NA after discharge        Yes          No      
     If no, what is the reason: _____________________________________________ 
          education provided and signed up to another meeting?             Completed 
 
b. After attending your first appointment after discharge, did you schedule your next 
appointment with your: 
 
• Primary care provider        Yes          No         N/A 
     If no, what is the reason: _____________________________________________ 
 
• Psychiatric provider        Yes         No        N/A    
     If no, what is the reason: _____________________________________________ 
 
• Sponsor meeting        Yes          No         
     If no, what is the reason: _____________________________________________ 
 
• AA/NA post- discharge        Yes          No         
     If no, what is the reason: _____________________________________________ 
 
 At 30 days after discharge 
a. Did you start using drugs/ drinking alcohol within a month after you get discharged from 
Crossroads? 
         if yes, education, necessary resources, and hotline numbers provided?                        Completed     
 
b. Health leads (After 30 days of discharge) 
         if new needs identified, provided resources and referred to SHOW                       Completed    
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Appendix N 
Instrument 3 
 Pre- Intervention Health Leads Survey & Post- Intervention Health Leads Survey 
Note: Removed due to Copyright 
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Appendix O 
Instrument 4 
 Assessment of Warning Signs of Relapse Questionnaire 
Please read the following statements and for each one circle a number, from 1 to 7, to indicate 
how much this has been true for you recently. Please circle one and only one number for every 
statement. 
 
Date of last alcoholic drink/ drug use: _____ 
 
 Never Rarely Sometimes Fairly 
Often 
Often Almost 
Always 
Always 
1. I feel nervous or unsure 
of my ability to stay sober. 
1 2 3 4 5 6 7 
2. I have many problems in 
my life. 
1 2 3 4 5 6 7 
3. I tend to overreact or act 
impulsively. 
1 2 3 4 5 6 7 
4. I keep to myself and feel 
lonely.   
1 2 3 4 5 6 7 
5. I get too focused on one 
area of my life.  
1 2 3 4 5 6 7 
6. I feel blue, down, listless, 
or depressed. 
1 2 3 4 5 6 7 
7. I engage in wishful 
thinking. 
1 2 3 4 5 6 7 
8. The plans that I make 
succeed. 
1 2 3 4 5 6 7 
9. I have trouble 
concentrating and prefer to 
dream about how things 
could be. 
1 2 3 4 5 6 7 
10. Things don’t work out 
well for me. 
1 2 3 4 5 6 7 
11. I feel confused. 1 2 3 4 5 6 7 
12. I get irritated or 
annoyed with my friends. 
1 2 3 4 5 6 7 
13. I feel angry or 
frustrated. 
1 2 3 4 5 6 7 
14. I have good eating 
habits. 
1 2 3 4 5 6 7 
15. I feel trapped and stuck, 
like there is no way out. 
1 2 3 4 5 6 7 
16. I have trouble sleeping. 1 2 3 4 5 6 7 
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17. I have long periods of 
serious depression. 
1 2 3 4 5 6 7 
18. I don’t really care what 
happens. 
1 2 3 4 5 6 7 
19. I feel like things are so 
bad that I might as well 
drink/use drugs. 
1 2 3 4 5 6 7 
20. I am able to think 
clearly. 
1 2 3 4 5 6 7 
21. I feel sorry for myself. 1 2 3 4 5 6 7 
22. I think about 
drinking/drug use. 
1 2 3 4 5 6 7 
23. I lie to other people. 1 2 3 4 5 6 7 
24. I feel hopeful and 
confident. 
1 2 3 4 5 6 7 
25. I feel angry at the world 
in general. 
1 2 3 4 5 6 7 
26. I am doing things to 
stay sober. 
1 2 3 4 5 6 7 
27. I am afraid that I am 
losing my mind. 
1 2 3 4 5 6 7 
28. I am drinking/using 
drugs out of control. 
1 2 3 4 5 6 7 
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Appendix P 
Figure 1 
 Project Recruitment Flyer 
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Appendix P 
Document 2 
 Informed Consent 
Improving the Care Transition to Outpatient Aftercare Services Following 
Addiction Treatment 
 
I am a family nurse practitioner student at Arizona State University (ASU). I am being 
guided by Dr. Carol Moffett, PhD, FNP- BC, who is faculty in the ASU College of Nursing and 
Health Innovations and who is the primary investigator for this study. We are inviting you to 
participate in this study because you are receiving treatment at Crossroads. This study is 
designed to help you connect with services after you leave Crossroads.  We want to see if 
connecting with these services can help prevent relapse. The study will take place while you are 
at Crossroads and for 30 days after you leave the center. If you agree to participate in this study, 
you can expect the following: 
 
• You will be asked to fill out four forms throughout the study. The time it takes to complete 
the forms may vary depending on your participation. 
a. Demographic Questionnaire—basic information about you: 5 minutes at the start 
of the study.  
b. AWARE (Advance Warning of Relapse) questionnaire filled out twice once at the 
beginning and again before leaving Crossroads: 5-10 minutes 
c. Health Leads Survey—questions about basic needs filled out twice once at the 
beginning and again 30 days after discharge: 5 minutes  
d. Post-intervention data collection form—questions about services, appointments, 
and relapse status filled out twice once just before leaving Crossroads and again 30 
days after discharge: 5 minutes 
• While in the study, we will ask for information about: 
a. What services you needed and used while at Crossroads. This information will also 
be taken from a form at Crossroads. 
b. What services you used in the 30 days after discharge. 
c. What problems you had finding and using services. 
 
• We will ask you to attend weekly 15- minute sessions during your stay at Crossroads. If you 
decided to extend your treatment beyond 30 days, sessions will be as needed basis until you 
leave the program.  
 
• After you leave Crossroads, message reminders will be sent within a week before your 
appointments  
 
• Follow- up messages will be sent:  
a) the day after your scheduled appointments with your doctor, 
b) the day after your first 12-step meeting,  
c) the day after your first sponsor meeting to ask about your attendance,  
d) 30 days after you leave the program to ask about any relapse and any services used.  
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• It is very important to collect complete information.  For this reason, you will be asked to 
provide at least two trusted contact persons. They will be called by the researcher to ask 
about your attendance with appointments and relapse status only if you cannot be reached. 
 
Depending on whether you have a smart phone, the information will be gathered either 
through iTether (a secure mobile application) or through surveys completed in-person, calls, text, 
and/or email messages. Your responses on the questionnaires will be confidential and will be 
stored in a locked box or in iTether only accessed by the research team. You will be identified 
using a 32-number combination for study reporting. The results of this study may be used in 
reports, presentations, or publications, but nothing identifying you will be used. Information you 
give in the study may be kept for future research.  
 
To be eligible for this study, you must be 18 years of age or older and must be able to 
speak and understand English. There is no known risk greater than those that are associated with 
everyday types of activity. Possible benefits include: a) improved access to needed medical and 
community support services, b) improved health and well-being because of increased access and 
engagement to needed services, and c) decreased risk of relapse.  
 
You are free to decide whether you want to participate in this study. Your choice to 
participate or not participate will not affect the care you receive in the center. You can leave the 
research at any time and it will not be held against you. Participation in this study will not affect 
your parole status. You will not be paid to participate in this study. Instead of being in this 
research study, you can choose to continue the regular care transition processes in the facility, 
which does not include those discussed above. 
 
If you have any questions concerning this program, please contact either Dr. Carol 
Moffett, PhD, FNP-BC, CDE, FAANP at Carol.Moffett@asu.edu or Roxanne Tenorio, BSN, RN, 
DNP student at rrtenori@asu.edu. If you have any questions about your rights as a participant in 
this project, or you feel you have been placed at risk, you can contact the Chair of the Human 
Subjects Institutional Review Board, through the ASU Office of Research Integrity and 
Assurance, at (480) 965-6788 or by email at research.intergrity@asu.edu. 
 
Thank you, 
Roxanne Tenorio, RN, BSN, DNP-FNP Student 
 
I certify that I am at least 18 years of age  
              
Yes            No 
I certify that I read and understood the information presented in the 
above consent letter. My questions and concerns (if any) about this research 
study have been addressed 
 
Yes            No 
I voluntarily consent to participation in this study (An answer of “Yes” 
will constitute your full agreement to participate in this study 
Yes            No 
 
____________________________________________________________ ____________ 
  Signature of participant                        Date 
____________________________________________________________ 
             Printed name of participant 
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Appendix R 
Document 3 
 Outline of Educational Sessions 
OUTLINE OF EDUCATIONAL SESSIONS 
Topic: Overcoming Addiction 
I. Utilize educational plan and tools while incorporating motivational interviewing with 
emphasis on the following: a) intrinsic motivation, b) importance of access and follow-up 
adherence to medical services, c) creating healthy social connections and activities 
(Sponsorship and AA/NA meetings), and d) relapse prevention. Educational sessions with 
motivational interviewing will be on a weekly basis for at least 15 minutes per session. 
 
A. Emphasis on intrinsic motivation 
1. Activity:  
- Goal discussion and problem- solving: Allow participant to prioritize needs and 
identify possible solutions to get access with these needs and obtain abstinence goals. 
Give support by providing necessary resources and tools  
 
B. Importance of engagement with medical services 
1. Individualized education regarding substance use disorder and effect to health 
2. Importance of healthcare engagement and substance use outcomes 
3. Importance of being open to healthcare providers 
4. Activity: 
- Schedule outpatient appointments (give support if needed) 
**Utilize and discuss appointment schedule form/iTether calendar 
 
C. Importance of creating healthy social connections and relapse prevention 
1. Understanding addiction 
2. Importance of repairing “old” support systems and creating “new” healthy   
relationships 
**Utilize resource book for community support 
3. Importance of attending AA/NA meetings and connecting with a sponsor 
4. Activity: 
- Schedule meeting with Sponsor weekly and after discharge (give support if needed) 
**Utilize and discuss appointment schedule form/iTether calendar 
- Schedule AA/NA meetings post- discharge 
**Utilize and discuss appointment schedule form/iTether calendar 
- Complete relapse prevention card 
> sponsor contact information 
> trusted person to call 
> list of enjoyable drug-free activities to do 
> hot line numbers to call 
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Appendix S 
Table 4 
Demographic Characteristics 
 x̄ SD (Range) n % 
Age 35.37 10.47 (20-59)   
Gender     
     Male   16 53.3 
     Female   14 46.7 
Race     
     Caucasian   13 43.3 
     Hispanic   9 30.0 
     African American   5 16.7 
     Native American   2 6.7 
     Asian   1 3.3 
Educational Level     
     Grade School Diploma   6 20.0 
     High School or Equivalent   14 46.7 
     Certificate/Training Program   4 13.3 
     Associate’s Degree   1 3.3 
     Bachelor’s Degree   4 13.3 
     Doctoral Degree   1 3.3 
Marital Status     
     Single   15 50.0 
     Married   9 30.0 
     Divorced   5 16.7 
     Separated   1 3.3 
Reason for Admission     
     Mandated/Pre-trial   10 33.3 
     Voluntary   19 63.3 
     Other   1 3.3 
Primary Substance of Choice     
     Alcohol   8 26.7 
     Cocaine   2 6.7 
     Heroin   6 20.0 
     Methamphetamines   10 33.3 
     Opioids   4 13.3 
Secondary Substance of Choice     
     Opioids   1 3.3 
     Benzodiazepines   2 6.7 
     Cocaine   2 6.7 
     Heroin   3 10.0 
     Methamphetamines   8 26.7 
     Marijuana   7 23.3 
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 x̄ SD (Range) n % 
     Other   4 13.3 
Presence of Medical Condition   13 43.3 
Medical Conditions     
     Hypertension   3 10.0 
     Heart Failure   2 6.7 
     Asthma   3 10.0 
     Diabetes   1 3.3 
     Thyroid Disease   1 3.3 
     Chronic Back Problem   2 6.7 
     Arthritis   4 13.3 
     Hepatitis   1 3.3 
     Sexually Transmitted Illness   2 6.7 
     Endocarditis   1 3.3 
     Hernia   1 3.3 
     Paresthesia   1 3.3 
Presence of Psychiatric Condition   11 36.7 
Psychiatric Conditions     
     Depression   7 23.3 
     Anxiety   7 23.3 
     Attention Deficit Disorder   1 3.3 
     Post-traumatic Stress Disorder   2 6.7 
     Eating Disorder   1 3.3 
     Paranoid Schizophrenia   1 3.3 
     Other Mood Disorder   1 3.3 
Prior Addiction Treatment   16 53.3 
History of Imprisonment   25 83.3 
History of Homelessness   19 63.3 
Insurance Provider     
     Medicaid   24 80.0 
     Private Insurance   2 6.7 
     Other   1 3.3 
     No Insurance     3 10.0 
Total Length of Stay     
     30 days   6 20.0 
     60 days   9 30.0 
     90 days   2 6.7 
     Other   9 30.0 
     Did not complete treatment   4 13.3 
Discharge Disposition     
     Sober living   3 10.0 
     Home   8 26.7 
     Halfway house   1 3.3 
     Quarter house   2 6.7 
     Lost to follow-up/ Relapsed   16 53.3 
Note.  n= number of participants; x̄= mean; SD= standard deviation. 
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Appendix T 
Table 5 
Comparison of Pre- and Post- Intervention Community Aftercare Needs 
Needs Pre-intervention  Post-intervention  McNemar Test 
Smart phone needs 12 2 .002* 
Food insecurity 11 4 .016* 
Housing instability 23 12 .001* 
Utility needs 9 3 .031* 
Financial resource strain 10 3 .016* 
Transportation needs 16 4 <.001* 
Exposure to violence 0 0 Not applicable 
Child care needs 4 2 .5 
Literacy needs 4 2 .5 
Unemployment 26 5 <.001* 
No insurance 5 3 .5 
Behavioral/Mental needs 12 4 .021* 
Social isolation 6 1 .063 
Dental care needs 15 14 1 
Eye care needs 14 9 .063 
Legal service needs 4 3 1 
Spiritual needs 4 1 .25 
Needs PCP 22 16 .031* 
Needs psychiatric provider 1 1 1 
Sponsor needs 13 3 .002* 
Support group needs 8 6 .5 
Note. n=30, significant result (p=<.05) are in bold with asterisk. PCP= Primary Care Physician. 
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Appendix U 
Figure 2 
Comparison Between Pre- and Post- Intervention Relapse Risk Percentages 
  
Figure 2. A Wilcoxon test examined the change in relapse percentage risk pre- and post- 
intervention (n=14). A significant difference was found in the results (Z= -3.180, p= .001), 
indicating reduction in relapse risk post- intervention. 
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Appendix V 
Figure 3 
Flowchart of Participant Enrollment and Retention 
 
Figure 3. n= number of participants. 
 
 
 
 
 
 
 
 
 
 
30 participants 
enrolled
4 relapsed in the 
facility 26 participants
12 were lost to 
follow-up prior 
to dischage
14 participants
6 were lost to 
follow-up after 
discharge
8 participants 
completed the 
study 
Male (n= 7) 
Female (n= 1) 
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Appendix W 
Table 6 
Follow-up Adherence and Engagement to Appointments Scheduled After Discharge 
 n FA CE 
PCP 10 9 8 
Sponsor 14 12 12 
Support group 13 12 12 
Note. n= number of participants with scheduled appointments; PCP=Primary Care Physician; 
FA= Follow-up adherence; CE= Continued engagement. 
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Appendix X 
Table 7 
Relapse Status at 30 days After Discharge 
 n % 
Did not relapse 8 27 
Relapse in the facility 4 13 
Lost to follow-up 18 60 
Note. n= number of participants. 
 
